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vAbstract 
Innate sensing of nucleic acids lies at the heart of antiviral host defense. 
However, aberrant activation of innate sensors by host nucleic acids can also 
lead to the development of autoimmune diseases. Such host nucleic acids can 
also be released from stressed, damaged or dying cells into the tissue 
microenvironment. It however remains unclear how the extracellular nucleic acids 
impacts the quality of the host immune responses against viral infections. Using 
a mouse model of influenza A virus (IAV) infection, we uncovered an important 
immune-regulatory pathway that tempers the intensity of the host-response to 
infection. We found that host-derived DNA from necrotic cells accumulates in the 
lung microenvironment during IAV infection, and is sensed by the DNA receptor 
Absent in Melanoma 2 (AIM2). AIM2-deficiency resulted in severe immune 
pathology highlighted by enhanced recruitments of immune cells, and excessive 
systemic inflammation after IAV challenge, which led to increased morbidity and 
lethality in IAV-infected mice. Interestingly, these effects of AIM2 were largely 
independent of its ability to mediate IL-1β maturation through inflammasome 
complexes. Finally, ablation of accumulated DNA in the lung by transgenic 
expression of DNaseI in vivo had similar effects. Collectively, our results identify 
a novel mechanism of cross talk between PRR pathways, where sensing of host-
derived nucleic acids limits immune mediated damage to virus infected tissues.  
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Chapter 1 
 
Introduction and Background 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2Introduction 
The immune system of vertebrates is a complex network of cells surveying its 
host for microbial invasion or damaged self and enacting the mechanisms for 
elimination of the threat and the return to homeostasis. The immune system can 
be broadly categorized into the innate and adaptive branches of immunity based 
on the receptors used in the sensing of “self” and “non-self”. The innate immune 
system uses a fixed set of receptors able to recognize a breadth of exogenous 
and endogenous molecules present in all forms of life. On the other hand, the 
receptors of the adaptive immune system are rearranged to recognize and 
respond to a specific antigen. The cooperation of these two systems not only 
protects us from the vast number of microbes in our environment, but it also 
mediates the removal of dysfunctional cells and repair in damaged tissues. The 
relatively slow kinetics of generating a targeted response by the adaptive 
response necessitates a broad antimicrobial and inflammatory response to 
contain the infection by the innate immune system. The recognition of molecular 
patterns conserved across all forms of life by the innate pattern recognition 
receptors is a paradoxical problem for the immune system in its efforts to 
distinguish between “damaged” versus “undamaged” while maintaining tolerance. 
While the robust inflammation generated by the innate immune system in 
response to infection is important for the survival of the host, the continuous draw 
of sterile inflammation stimulated by endogenous molecules can spur the 
development of autoimmunity, allergy, cancer, and immune pathology. The ever-
3present microflora on our bodies and persistent viruses, lying quietly past every 
barrier of the cell or even infiltrating our genome, further adds to the complexity of 
regulating innate immunity and inflammation.  
Nucleic acids are present in all forms of life, yet the innate immune system 
of mammals has developed strategies to recognize abundant and misplaced 
nucleic acids as viral infection requiring an antiviral response. New insights into 
the genesis of autoimmunity and autoinflammation have implicated the 
continuous sensing the host’s own nucleic acids as a driver of pathology and 
disease, thereby highlighting the complicated balancing act that is maintaining 
tolerance while providing protection. In this dissertation I focus on the 
mechanisms utilized by the innate immune system for the sensing of infection 
with a DNA virus and host DNA in tissues damaged by virus. Understanding the 
mechanisms of molecular recognition and responses downstream by the innate 
immune system will not only be useful for developing new and better vaccines 
against pathogens but also for effective immunotherapies targeting tumors.  
 
 
 
 
 
 
 
4Molecular patterns stimulate the innate immune response 
The immune response to infection in vertebrates ultimately culminates in the 
formation of a protective antigen-specific adaptive response. Nonetheless, the 
detection of the pathogen by the innate immune system must first occur. That is 
to say, the stimulation of innate immune responses is required for the 
development of the adaptive response to a particular pathogen. Notification of 
damage to the immune system similarly requires recognition by the cells of the 
innate immune branch for the removal and repair of damaged tissue. The innate 
phase of the immune response is spurred by the sensing of “molecular patterns” 
broadly conserved across kingdoms of life to react to damage derived from both 
exogenous and endogenous sources. These immunostimulatory molecules are 
collectively termed pathogen-associated molecular patterns (PAMPs) when found 
in the macromolecular structures of the pathogen, while endogenous molecules 
are referred to as damage-associated molecular patterns (DAMPs). The innate 
immune system recognizes the molecular signature of PAMPs and DAMPs 
through a set of germline-encoded proteins called pattern recognition receptors 
(PRRs). PAMPs and DAMPs take on a wide array of molecular structures 
including carbohydrates, lipids, proteins, and nucleic acids. The recognition of 
broad molecular patterns, particularly in the case of nucleic acids, is a means for 
the immune system to survey for damage, in addition to the detection of microbial 
invasion. While the carbohydrates, lipids, and proteins of bacteria, viruses, and 
fungi may only contain small differences in their molecular structure, receptors of 
5the innate immune system have evolved as such to distinguish between host cell 
and microbial molecules. On the other hand, nucleic acids are the genetic basis 
of life for both microbes and host alike, and aside from the order nucleotide 
sequence, they are largely indistinguishable. Thus, the recognition of both host 
and microbial nucleic acids must be regulated by the innate immune system to 
prevent unwanted responses.  
 
Immunostimulatory Activity of Nucleic Acids: A Brief History 
The antiviral effect of foreign nucleic acids on cells was appreciated well prior to 
the discovery of the innate immune system and its function. In 1957, Isaacs and 
Lindemann reported that infection of eggs with heat-inactivated influenza A virus 
triggered the release of a factor able to interfere with subsequent infection and 
replication of live virus (Isaacs and Lindenmann, 1957). They dubbed these 
unknown molecules “interferons” (IFNs) based on their activity and interference 
of viral infection. While it was clear even the non-viable virus could stimulate the 
production of interferon in cells, it was unknown for some time what viral 
molecules were recognized by the cell as “foreign” and induced interferon. A clue 
into the identity of the viral molecule required for interference came in a 1958 
article by Paucker and Henle reporting that influenza virions lacking viral RNA did 
not stimulate IFN (Paucker and Henle, 1958). With some insight from these 
findings, Rotem and colleagues demonstrated in their 1963 Nature paper that the 
addition of either purified RNA or DNA to cells prior to infection interfered with the 
6replication of both DNA or RNA viruses (Isaacs and Lindenmann, 1957; Rotem et 
al., 1963). Importantly, they found nucleic acids induced interferon without regard 
to the source, as RNA and DNA from chickens, mice, and cows were all able to 
interfere with virus replication, thus viral and eukaryotic nucleic acids were 
indiscriminately sensed by the cells for IFN induction. Despite this finding 
however, much of the efforts in the following few decades focused on defining the 
molecular signature that marked viral nucleic acids as “foreign” in a sea of 
cellular nucleic acids so that it might be mimicked for therapeutic uses. Studies 
by the Hilleman group lead to the discovery of the polymer 
polyriboinosinic:polyribocytidilic acid (poly I:C), a long double-stranded RNA 
synthetic, as potent inducer of IFN (Paucker and Henle, 1958; Field et al., 1967). 
The identification of long dsRNA as the inducer of IFN immediately made clear 
that there was some level of discrimination by the host in identifying nucleic 
acids. While long dsRNA genomes and replication species are common during 
lytic viral replication, eukaryotic cells do not have any long dsRNA species to be 
recognized (Hilleman, 1970). Since that time, uncapped single stranded RNAs 
with 5’-phosphates or panhandle secondary structure have been shown to also 
induce IFN production (Hornung et al., 2006; Pichlmair et al., 2006; Wu and 
Chen, 2014). Thus, the number of species, sizes, and modifications of RNA 
provide a mechanism of distinction between “self” versus “non-self” by the innate 
immune system. 
7 A number of other molecular characteristics required for the 
immunostimulatory activity of DNA have also been described over the past 30 
years. Bacterial DNA and palindromic synthetic oligodeoxynucleotides (ODNs) 
with unmethylated CpG motifs were found to stimulate B cell proliferation and the 
antitumor activity of NK cells (Yamamoto et al., 1992; Krieg et al., 1995). Unlike 
the RNA, the stimulatory activity of DNA can depend greatly on the nucleotide 
sequence. ODNs containing TTAGGG repeats abundant in telomeric DNA 
mimics the immunosuppressive effect of self-DNA (Klinman et al., 2008).  
These early efforts have highlighted the potent immunostimulatory activity 
of nucleic acids and garnered much attention for its therapeutic potential since its 
discovery. It is important to note that in the studies mentioned above, the 
induction of IFN and inflammatory genes was in response to extracellular nucleic 
acids confirming either the presence of cell surface receptors able to sense RNA 
and DNA or, mechanisms directing them to subcellular compartments for 
recognition. However, work over the last 10 years has found that the delivery of 
DNA and RNA to the cytosol also induces potent IFN and inflammatory 
responses through a distinct set of receptors than those sensing extracellular 
nucleic acids. 
 
Pattern Recognition Receptors for Nucleic Acids 
Toll-like Receptors 
8With the discovery of the immunostimulatory activity of nucleic acids, the next 
obvious question became: what receptors were recognizing nucleic acids and 
inducing a response downstream? The Toll-like receptors (TLRs) were the first 
family of PRRs in vertebrates to be identified for their ability to recognizing 
PAMPs and stimulate innate immune responses. First found in fruit flies, the Toll 
receptor of fruit flies induced expression of antimicrobial peptides in response to 
bacterial infection (Lemaitre et al., 1996). The TLRs are type I transmembrane 
proteins consisting of a leucine-rich repeat (LRR) extracellular domain for the 
recognition and binding of PAMPS, and cytosolic Toll/Interleukin-1 receptor (TIR) 
domain to initiate intracellular signaling. The work of Medzhitov and Janeway first 
highlighted the importance of TLR signaling in stimulating early inflammatory 
cytokine production and the expression of co-stimulatory molecules necessary for 
activation of the adaptive response in mammalian cells (Medzhitov et al., 1997). 
The subsequent discovery of TLR4 as the much sought after receptor for the 
lipopolysaccharide (LPS) from the cell wall of gram-negative bacterium prompted 
a flurry of work identifying a number of other TLRs in the ensuing years (Poltorak 
et al., 1998). To date, 13 TLRs in mice and 10 in humans have been identified 
with TLRs 1-9 being shared by both species. The TLR family can be categorized 
into two groups based on their location in the cell and the molecular patterns of 
the ligands they recognize. Located at the plasma membrane are TLRs 1, 2, 4, 5, 
and 6 with their LRR domains facing the extracellular side for the detection of 
extracellular PAMPs. The cell surface TLRs recognize PAMPs primarily bacterial 
9in origin including flagellin, peptidoglycan, lipoproteins, LPS, etc (O’Neill, 2008). 
In addition to those at the cell surface, the nucleic acid sensing TLR3, 7, 8, and 9 
are localized to the endosomal compartment. For the purposes of this 
dissertation I will focus our discussion on the nucleic acid sensing TLRs. 
 
Nucleic Acid Sensing TLRs  
Work in the Akira lab identified TLR9 as the receptor for unmethylated CpG DNA, 
showing it was required for NF-κB activation and inflammatory response to CpG 
ODN (Hemmi et al., 2000). Soon after TLR3 was found to be the receptor for poly 
I:C and long dsRNA (Alexopoulou et al., 2001).TLR7 and 8 recognize ssRNA of 
viral genomes and replication intermediates and small molecule nucleoside 
analogs (Hemmi et al., 2002; Diebold et al., 2004). Dimerization to the TLRs 
initiates intracellular signaling by differentially recruiting the adaptor proteins 
myeloid differentiation primary response protein 88 (MyD88) or TIR-domain-
containing adapter inducing IFN (TRIF). Signaling downstream of TRIF and 
MyD88 proceeds through two distinct pathways, and deletion of both MyD88 and 
TRIF completely blocks signaling downstream of TLR stimulation. TLR3 recruits 
TRIF to its cytosolic TIR domain activating the tank binding kinase 1 (TBK1) 
complex to phosphorylate the transcription factors interferon regulatory factor 3 
and 7, which are required for type I IFN induction (Fitzgerald et al., 2003). TRIF 
also activates receptor interacting protein 1 (RIP1) kinase, which then activates 
the NF-κB pathway (Meylan et al., 2004). TLR4 signals through both TRIF and 
10
MyD88, whereas MyD88 is required for signaling by the remaining TLRs. 
Recruitment of MyD88 to TLRs leads to activation of IL-1 receptor associated 
kinases (IRAK), which activates the NF-κB and the mitogen-activated kinase 
(MAPK) pathways (Motshwene et al., 2009). NF-κB, IRF, and MAPK activation 
downstream of TLR stimulation results in upregulation of inflammatory 
cytokines/chemokines, type I IFNs, co-stimulatory molecules, and antigen 
presentation to provide the critical input signals necessary for initiating the 
adaptive response.  
 The main function of the endolysosomal network is the transport of cargo 
from the extracellular environment or cell surface for degradation, with the pH of 
the lumen becoming more acidic as the endosome matures. The specific 
localization of nucleic acid sensing TLRs suggests the conditions in the lumen of 
the endosome are somehow important for their recognition of nucleic acids. 
Acidification of the endolysome is indeed required for recognition of CpG DNA by 
TLR9 (Lund et al., 2003). The endosomal location of TLRs is a physical 
mechanism preventing the unwanted sensing of self-nucleic acids, with DNA 
confined to the nucleus, and RNA present in both the nucleus and cytoplasm. 
Mislocalization of TLR9 to the cell surface was unable to respond to viral DNA 
but acquired the ability to respond to self-DNA (Barton et al., 2005). Thus, the 
endosomal localization of TLR9 prevents unwanted recognition of self-DNA in the 
extracellular environment and nucleus. Expression of TLR3, 7, 8, and 9 varies 
amongst different cell types of the innate immune system suggesting certain cells 
11
might be better specialized for nucleic acid sensing. For example, plasmacytoid 
dendritic cells (pDC) express high levels of TLR7 and 9 and produce large 
amounts of IFN-α,when stimulated through these pathways. 
 
Cytosolic Nucleic Acid Sensors 
The uptake of foreign nucleic acids into the endosome is important for its 
detection by nucleic acid-sensing TLRs, however many viruses and intracellular 
bacteria bypass the endosome during entry and enter directly into the cytosol. 
Regardless of their site of replication in the cell, viral transcripts, genomes, and 
replication intermediates all gain access to the cytosol at some point during lytic 
infection. Evidence supporting the existence of cytosolic nucleic acid sensors 
came in 2003, when it was found that delivery of poly I:C directly to the cytosol by 
transfection or electroporation induced high levels of type I IFN in a TLR3- and 
MyD88-independent manner (Diebold et al., 2003). Similarly, delivery of DNA 
directly to the cytosol induces type I IFN and proinflammatory cytokines 
independent of TLR signaling but required IRF3 (Stetson and Medzhitov, 2006). 
The discoveries spurred considerable efforts to identify the cytosolic receptors 
able to sense cytosolic nucleic acids over the last decade. 
 
RIG-I-like Receptors 
RIG-I-like receptors (RLRs) were first identified as the receptors for cytosolic 
RNA. The family consists of three identified members: retinoic acid-inducible 
12
gene I (RIG-I), melanoma differentiation-associated gene 5 (MDA-5), and 
laboratory of genetics and physiology 2 (LGP-2). All the RLRs belong to the 
DExD/H box RNA helicase superfamily, containing a DExD/H box domain with 
ATPase activity and a C-terminal repressor domain (RD). RIG-I and MDA-5 have 
tandem N-terminal caspase activation and recruitment domains (CARD) required 
for their signaling upon sensing cytosolic RNA, however LGP-2 lacks any CARD 
domain.  
 The RLRs all bind to dsRNA species, but each have more specific 
requirements in RNA modifications and the length of the RNA due to their distinct 
mechanisms of recognizing invading dsRNA. RIG-I recognizes short blunt-ended 
dsRNAs bearing a 5’-triphosphate, a modification not present on host mRNA, or 
short hairpin ssRNA found in negative-sense viruses such as Influenza A virus 
(IAV) and vesicular stomatitis virus (VSV) (Schlee et al., 2009; Baum et al., 2010). 
RNA Polymerase III (Pol III) has also been shown to generate short ssRNA 
transcripts using AT-rich DNA in the cytosol as template, and these are also 
recognized by RIG-I (Ablasser et al., 2009). RIG-I is present in the cytosplasm in 
an auto-inhibited state undergoing a conformational change upon binding to 
dsRNA, allowing its ubiquitination by tripartite motif protein 25 (TRIM25) (Gack et 
al., 2007). MDA-5 on the other hand, recognizes long dsRNA found in the 
picornaviruses encephalomyocarditis virus (EMCV) and polio virus (PV), amongst 
others. MDA-5 binds and oligmerizes on long dsRNAs forming large filament 
structures (Bin Wu et al., 2013). 
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MDA-5 and RIG-I both signal through the adaptor protein mitochondrial 
antiviral signal (MAVS), also known as VISA and IPS-1, located on the outer 
membrane of mitochondria and peroxisomes by homotypic interaction of their 
CARD domains. (Xu et al., 2005; Dixit et al., 2010). MAVS is required for all 
signaling downstream of RLRs with the exception of LGP-2 due to it lacking a 
CARD domain to bind to MAVS. Currently, the function of LGP-2 is not clear but 
is thought to negatively regulate RIG-I and MDA-5 signaling. Activation of the 
MAVS-dependent pathway occurs through its aggregation on the surface of the 
mitochondria stimulated by the binding of activated RIG-I or MDA-5 filaments. 
TNF receptor associated factor (TRAF) 3 and 6, caspase-8, RIP1, FAS-
associated death domain (FADD), and TNF receptor-associated death domain 
(TRADD) are recruited to activated MAVS, forming a signaling complex for 
activation of the kinases IKKα/β and TBK1, resulting in downstream NF-kB- and 
IRF3/7-dependent transcription of inflammatory and antiviral genes (Figure 1.1) 
(Kawasaki et al., 2011).  
 Unlike TLR3, 7, and 8 which respond to extracellular nucleic acids, the 
RLRs only recognize cytosolic RNA, suggesting they exist specifically for the 
detection of incoming and replicating RNA viruses and the stimulation of innate 
immune responses. Studies using knock-out mouse models have confirmed the 
importance of MAVS-dependent signaling for stimulating protective innate 
immune responses to RNA virus infection (Kumar, 2006). RNA viruses can be 
categorized by their dependency on RIG-I or MDA-5 for their detection. Most 
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RNA viruses have either positive, negative, or ambisense single-stranded RNA 
genomes and as such, the majority of RNA viruses activate RIG-I signaling. 
Some notable examples of viruses recognized by RIG-I include IAV, VSV, Sendai 
virus (SeV), hepatitis C virus (HCV), and ebola virus (Takeuchi and Akira, 2009). 
MDA-5 however, detects the long dsRNA genomes and replication intermediates 
present in a smaller number of RNA virus families including EMCV, PV, 
coxsackie B virus (CBV), and Theiler’s murine encephalomyelitis virus (TMEV) 
(Kato et al., 2006).  
 
Cytosolic DNA Sensors for IFN induction 
Delivery of dsDNA to the cytosol during DNA virus infection or by transfection 
induces the type I IFN and inflammatory cytokine responses in a TLR-
independent manner (Stetson and Medzhitov, 2006). However, unlike the 
modifications to RNA required for their recognition by RLRs, any dsDNA longer 
than 25bp with a sugar-phosphate backbone is able to stimulate innate immune 
responses when delivered to the cytosol. DNA present in the cytoplasm is clearly 
an indicator of infection or stress since it is normally confined to the nucleus and 
mitochondria in eukaryotic cells. Thus, separating ligand and receptor into 
different subcellular compartments prevents the unwanted activation of the innate 
immune responses to self-DNA. 
The first key finding towards identifying the components necessary for the 
sensing of cytosolic DNA upstream of the IFN response was the discovery of 
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adaptor protein stimulator of interferon genes (STING). Similar to MAVS, STING 
was identified for its ability to drive type I IFN production when overexpressed 
(Ishikawa and Barber, 2008). STING is required for the stimulation of the innate 
immune response by cytosolic DNA, regardless of the receptor recognizing the 
foreign DNA.  Four hydrophobic α-helices localize STING to the outer membrane 
of the endoplasmic reticulum (ER), however it relocalizes to the Golgi forming 
large aggregates after cytosolic DNA signaling (Ishikawa et al., 2009). The 
STING signaling complex recruits TBK-1, stimulating its kinase activity and 
phosphorylation of its substrates IRF3 and IRF7 (Ishikawa et al., 2009). Cytosolic 
DNA signaling also activates the NF-κB pathway in a STING-dependent manner, 
but how this occurs is unknown. STING is absolutely required for inducing type I 
IFN and inflammatory responses to cytosolic DNA and DNA virus infection. Mice 
deficient for STING have impaired IFN and inflammatory cytokine responses, and 
are susceptible to HSV-1 infection (Ishikawa et al., 2009). Interestingly, STING-/- 
mice are also susceptible to VSV infection suggesting it may also have a role in 
the pathogenesis of RNA viral infection, perhaps through the sensing host DNA 
released into damaged tissues (Ishikawa et al., 2009). 
In addition to serving as an adaptor downstream of cytosolic DNA sensors, 
the C-terminal domain of STING directly recognizes bacterial cyclic-dinucleotides 
(CDN) through its C-terminal domain resulting in its dimerization and activation of 
TBK1 and NF-κB signaling. Bacteria often utilize CDNs as secondary 
messengers in intracellular signaling pathways. For example, cyclic-adenosine 
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monophosphate (cAMP) and cyclic-guanine monophosphate (cGMP) from the 
bacterium V. cholerae stimulates type I IFN in a STING-dependent manner 
(Burdette et al., 2011). In addition to bacterial CDNs, the enzyme, cyclic-GMP-
AMP synthetase (cGAS), has recently been identified in vertebrates, with its 
enzymatic activity producing endogenous cyclic-GMP-AMP (cGAMP) in a DNA-
dependent manner upstream of STING activation. 
 
cGAS 
Though it is clear that STING is a direct sensor of CDNs and an adaptor required 
for type I IFN responses to cytosolic DNA, the identities of the cytosolic DNA 
receptors and enzymes upstream of STING have only recently been uncovered. 
Of the cytosolic DNA receptors identified, the activity of cGAS is the only one 
thus far with a clear mechanism coupling its activity to STING activation. cGAS is  
a member of the nucleotidyltransferase (NTase) family of enzymes able link 
nucleotide monomers into oligomers and other higher order structures. After 
activation by direct binding to cytosolic DNA, cGAS catalyzes the formation of 
cGAMP from ATP and GTP as a secondary messenger able to stimulate STING 
activation (Sun et al., 2013; Li et al., 2013a; Zhang et al., 2013b; Ablasser et al., 
2013b). Structural studies have confirmed cGAMP is able to directly bind to the 
C-terminus of STING, stimulating its dimerization and activation (Shu et al., 2012; 
Huang et al., 2012). Whether or not cGAMP functions as a secondary messenger 
exclusively for the response to cytosolic DNA is currently unknown, but it is likely 
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to activate other signaling pathways yet to be identified. cGAMP appears activate 
STING signaling in adjacent cells by passing through gap junctions, 
demonstrating cGAMP also functions as an intercellular signal for inducing type I 
IFN (Ablasser et al., 2013a). Deletion of cGAS in macrophages, dendritic cells, 
and fibroblasts completely abrogates IRF3 activation and downstream type I IFN 
responses to transfected DNA and DNA virus infection (Li et al., 2013b). The 
generation of cGAS-deficient mice has confirmed its importance in the immune 
response to DNA virus infection. Mice deficient for cGAS are susceptible to 
infection with herpes simplex virus-1 (HSV-1) and vaccinia virus (VACV), and had 
higher viral loads during latent infection with mouse γ-herpesvirus 68 (MHV-68) 
(Li et al., 2013b) (Schoggins et al., 2014). 
 
DAI 
The DNA–dependent activator of IRFs (DAI) was the first potential cytosolic DNA 
receptor to be identified. DAI binds to Z-form DNA by its N-terminal Z-α and Z-β 
domains, as well as to B-form DNA through its D3 domain. In the initial report 
identifying DAI as a receptor for the induction of type I IFN, its overexpression 
drives type I IFN responses in mouse L929 cells, and its knockdown diminished 
this response to cytosolic DNA (Takaoka et al., 2007). However, later studies 
using cells from DAI-deficient mice found normal type I IFN responses to 
cytosolic DNA in the absence of DAI. Thus it is unclear whether or not DAI is a 
bona fide DNA receptor for the induction of IFN. Recent work has found DAI 
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positively regulates programmed necrosis through its interaction with RIP3 during 
MCMV infection (Upton et al., 2012).  
 
IFI16/p204 
Interferon-inducible gene 16 (IFI16) is a member of the pyrin and HIN domain 
(PYHIN) family of proteins, a family of conserved proteins containing a PYRIN 
domain and at least one or more HIN-200 domain able to bind directly to dsDNA 
in a sequence-independent manner (Schattgen and Fitzgerald, 2011). IFI16 was 
first identified as a putative sensor by its affinity to dsDNA in pulldow assays 
using human cell extracts (Unterholzner et al., 2010). Though mice lack a clear 
homolog to IFI16, the mouse PYHIN p204 is the closest in secondary structure to 
IFI16 and thought to be its homolog. The role of IFI16 as a cytosolic DNA sensor 
is controversial with its requirement for IFN induction varying between studies. 
Knockdown of IFI16 or p204 in human THP-1 cells and mouse macrophages, 
respectively, partially inhibited IRF3 activation and IFN responses to transfected 
DNA and HSV-1 infection (Unterholzner et al., 2010). Similar results were found 
in response to infection with human immunodeficiency virus (HIV) (Jakobsen et 
al., 2013). However, other reports have found knockdown of IFI16 had no effect 
on the response to cytosolic DNA. A confounding detail in determining the 
function of IFI16 is its localization in the nucleus and cytoplasm varies between 
cell types (Li et al., 2012). Indeed, IFI16 appears to sense HSV-1 and Kaposi’s 
sarcoma-associated herpesvirus (KSHV) genomic DNA in the cytosol and 
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nucleus, respectively (Kerur et al., 2011) (Johnson et al., 2013). Besides its 
potential role as a redundant DNA sensor for stimulating the IFN response, IFI16 
has also been described to positively regulate the transcription of interferon 
stimulate genes (ISGs) in response to RNA virus infection as well (Thompson et 
al., 2014). Future studies using p204 knock-out mice and IFI16 knock-out human 
cell lines will better delineate its role in cytosolic DNA sensing.  
 
DDX41 
An RNAi screen of DExD/H helicases family members identified DEAD (Asp-Glu-
Ala-Asp) box polypeptide 41 (DDX41) as a putative cytosolic DNA sensor. 
Depletion of DDX41 was found to inhibit the IFN response to cytosolic DNA and 
HSV-1 infection (Zhang et al., 2011). DDX41 directly binds to DNA by its DEADc 
domain and has recently been shown to directly bind to CDNs upstream of 
STING (Parvatiyar et al., 2012). Other studies have found no role for DDX41 in 
the IFN response to cytosolic DNA however, thus further study in DDX41-
deficient mice will clarify its function in vivo.  
 
DNA-PK and MRE11 
In addition to the newly discovered putative DNA sensors, proteins well described 
to be involved in the DNA damage response (DDR) have also been implicated in 
the sensing and signaling by cytosolic DNA. The DNA-dependent protein kinase 
(DNA-PK) was identified as a potential DNA sensor for cytosolic DNA and DNA 
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virus infection. DNA-PK is a holoenzyme consisting of three subunits: the DNA 
binding proteins Ku70/Ku80 and the catalytic subunit DNA-PKcs. Studies in DNA-
PK-deficient mice showed attenuation but not abolishment of the IFN response to 
VACV infection (Ferguson et al., 2012). Recently, the DNA damage sensor 
meiotic recombination 11 homolog A (MRE11) was reported to be a cytosolic 
dsDNA sensor that activates the STING pathway. Studies using human cells 
bearing a MRE11 hypomorph showed it to be required for the type I IFN 
response to cytosolic DNA but not HSV-1 (Kondo et al., 2013). The identification 
of DNA-PK and MRE11as important for the response to cytosolic DNA clearly 
suggest cross-talk exists between the DDR and cytosolic nucleic acids sensing 
pathways.  
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Activation of the Inflammasome Complex by Cytosolic Nucleic Acids 
In addition to the induction of type I IFN, nucleic acids in the cytosol are also 
sensed by a distinct set of sensors for activation of the inflammasome complex. 
The inflammasome is a large multimeric complex consisting of a receptor, the 
adaptor protein Apoptosis-Associated Speck-Like Protein Containing A CARD 
(ASC), and its effector protein cysteinyl aspartate proteases-1 (caspase-1) (Davis 
et al., 2011). Most of the receptors identified for the activation of the 
inflammasome belong to the Nod-like receptor (NLRs) family of PRRs. Sensing of 
cytosolic perturbations in the form of PAMPs and DAMPs triggers the assembly 
of the inflammasome complex resulting in the activation of caspase-1. Two 
important substrates of caspase-1 are the inactive forms of IL-1β and IL18 in the 
cytoplasm. Activated caspase-1 cleaves pro-IL-1β and pro-IL18 into their mature, 
bioactive forms whereupon they are secreted from the cell. Caspase-1 activation 
also triggers an inflammatory form of cell death dubbed pyroptosis where the 
intracellular contents of the cell are released into the microenvironment where 
they stimulate inflammatory responses in cells recognizing DAMPs. 
Inflammasome activation, regardless of the activating receptor, requires two 
signals: (1) TLR-dependent upregulation of inflammasome components and 
substrates (i.e. IL-1β) and (2) sensing of the activating signal by the receptor and 
subsequent processing of caspase-1.   
 A number of inflammasome receptors have been described to sense and 
respond to a wide variety of cytosolic molecules of microbial and endogenous 
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origin. Here, I will discuss those receptors shown to sense cytosolic nucleic acids 
for activation of the inflammasome complex. 
 
NLRP3 
NLRP3 is the best studied of the inflammasomes sensors. Like most other NLRs, 
NLRP3 has an N-terminal PYRIN domain, a central nucleotide binding domain 
(NBD), and a large LRR domain in its C-terminus. Upon assembly of the 
inflammasome complex, NLRP3 interacts with ASC through homotypic PYRIN 
domain interactions to form a large multimeric complex, which then recruits 
caspase-1 to ASC through interaction of their CARD domains, ending with auto-
proteolytic processing of caspase-1 into its active form. The NLRP3 
inflammasome is activated in response to a diverse array of exogenous and 
endogenous molecules including bacterial pore-forming toxins, uric acid and 
cholesterol crystals, silica particles, high concentrations of extracellular ATP, and 
nucleic acids to name just a few (Martinon et al., 2009). Notably, there is no 
evidence supporting direct binding and recognition of the activating stimuli by 
NLRP3. Rather the evidence on NLRP3 suggests it is a sensor of the cytosolic 
state, responding to changes in the intracellular environment. Despite intensive 
study, there is no unified mechanism for activation of the NLRP3 inflammasome. 
Reactive oxygen species (ROS), potassium efflux from the cell, and lysosomal 
rupture leading to the leakage of cathepsin proteases have been implicated as 
the mechanisms of NLRP3 activation (Davis et al., 2011). Thus, it remains to be 
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seen whether NLRP3 activation occurs through a common mechanism or more 
specific means depending on the nature of the stimulus.   
In addition to alerting the innate response for induction of IFN and antiviral 
defenses, nucleic acids are also sensed in the cytosol by the inflammasome. IL-
1R signaling plays a key role in defense to bacterial and viral infections, thus their 
sensing and activation of the inflammasome are important events during the 
innate immune response. A number of RNA and DNA viruses have been found to 
activate the inflammasome in an NLRP3-dependent manner including: IAV, SeV, 
Hepatitis C virus (HCV), VSV for RNA viruses; and HSV-1, Modified vaccinia 
virus Ankara (MVA) and adenovirus (AdV) for DNA viruses (Kanneganti, 2010). 
Purified IAV vRNA and poly I:C delivered into the cytosol is sensed by the NLRP3 
inflammasome stimulating IL-1β processing and secretion (Allen et al., 2009). 
IAV infection has also been shown to activate the NLRP3 inflammasome by 
disrupting intracellular ion gradients with insertion of the IAV M2 ion pore into the 
Golgi network (Ichinohe et al., 2010). Studies in mice have shown NLRP3 is 
dispensable low dose IAV infection but is required for protection to higher doses 
of virus. ASC, caspase-1, and IL-1R are all required for the development of flu-
specific T and B cell responses and protection from IAV infection, regardless of 
the dose (Allen et al., 2009; Ichinohe et al., 2009; Pang et al., 2013; Thomas et 
al., 2009). How NLRP3 senses cytosolic RNA is unclear since it does not directly 
bind to RNA. Recent works have implicated sensing of mitochondrial dysfunction 
by NLRP3 as the mechanism for RNA recognition. Mitochondrial damage by 
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RNA virus infection requires activation of the RIP1-RIP3 complex, leading to ROS 
production and NLRP3 inflammasome activation (Wang et al., 2014). 
Interestingly, inflammasome activation in response to DNA virus infection does 
not require RIP3 indicating the sensing of RNA and DNA viruses by NLRP3 does 
not occur through the same mechanism (Wang et al., 2014). Delivery of dsDNA 
activates the inflammasome complex independent of NLRP3, making it unclear 
how NLRP3 senses DNA virus infection. Processing of IL-β in response to 
transfected DNA as found to require ASC and caspase-1 however, indicating 
another receptor was able to assemble an inflammasome in the presence of 
dsDNA. 
 
AIM2 
Absent in melanoma 2 (AIM2) was discovered to be the receptor necessary for 
inflammasome activation in response to dsDNA. AIM2 is also a member of the 
PYHIN family of proteins and as such has an N-terminal PYRIN domain coupled 
to a HIN-200 domain on the C-terminus required for binding to dsDNA. As with 
other inflammasome receptors, AIM2 forms an inflammasome complex by 
binding ASC through interaction of their PYRIN domains in turn recruiting 
caspase-1. Unlike the wide array of insults indirectly sensed by NLRP3, dsDNA 
binds directly to AIM2 to trigger inflammasome activation. Structural study shows 
the positive charge of the HIN-200 domain binds to the negatively charged sugar-
phosphate backbone of dsDNA across the major and minor grooves, meaning 
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ssDNA is unable to form stable complexes with AIM2 (Jin et al., 2012). Binding of 
DNA to AIM2 is independent of nucleotide sequence, but the dsDNA must be at 
least 80bp in length. Transfection of synthetic, mammalian, or microbial DNA all 
equally activates the AIM2 inflammasome. 
 DNA leaked into the cytosol by invading intracellular bacteria and the DNA 
viruses activates the AIM2 inflammasome leading to the processing and 
secretion of IL-1β and IL-18. AIM2 is required for IL-1β production by 
macrophages and dendritic cells in response to infection with the intracellular 
bacterium Francisella tularensis and Listeria monocytogenes, as well as the DNA 
viruses VACV and murine cytomegalovirus (MCMV) (Tsuchiya et al., 2010) 
(Rathinam et al., 2010; Fernandes-Alnemri et al., 2010; Jones et al., 2010). 
Unable to control the bacterial burden, mice deficient for AIM2 are susceptible to 
Francisella tularensis infection (Fernandes-Alnemri et al., 2010). AIM2-defiency 
in the case of MCMV infection lead to increased viral titers due decreased NK 
cell activation, likely a result of decreased IL-18R signaling. (Rathinam et al., 
2010). UV-treatment of MCMV severely blunts activation of the AIM2 
inflammasome suggesting its replication is somehow required for recognition by 
AIM2. Despite its clear specificity for dsDNA, one would hypothesize that the 
AIM2 is required for inflammasome activation in response to all DNA virus 
infections. Surprisingly, inflammasome activation by infection with the 
herpesviruses HSV-1 and MHV-68 is independent of AIM2, rather, they require 
NLRP3. How AIM2 is able to recognize some DNA viruses and not others is 
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unclear, but future studies will yield insight into the determinants of 
inflammasome activation by DNA virus infection. 
 
IFI16 
Recent works have suggested in addition to its role positively regulating IFN 
induction in response to cytosolic DNA, IFI16 may also function as an 
inflammasome receptor. IFI16 was found to co-localize with ASC and caspase-1 
around the periphery of the nucleus in KSHV infected endothelial cells, and in the 
cytosol of fibroblasts infected with HSV-1 (Kerur et al., 2011). Knockdown of 
IFI16 was found to block processing of caspase-1 and IL-1β in response to KSHV 
and HSV-1 but not VACV infection (Johnson et al., 2013). Abortive infection of 
CD4+ T cells with HIV triggers cell death in an IFI16- and caspase-1-dependent 
manner adding further evidence for caspase-1 activation by IFI16 (Monroe et al., 
2014). However, other works have reported IFI16 is unable to form an 
inflammasome in other cell types meaning further work is necessary to define the 
cellular contexts in which IFI16 associates with ASC and caspase-1 (Hornung et 
al., 2009). 
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Herpesviruses 
 The herpesviruses are a family of large DNA viruses able to establish 
lifelong latent infection in their host. All herpesviruses have a large, linear dsDNA 
genome encoding genes categorized as immediate early (IE), early (E), and late 
(L) genes depending when during the viral life cycle they are expressed. 
Herpesviruses have been found in a large and growing number of vertebrates 
species and as a result of co-evolution over millions of years, are often able to 
naturally infect only their host (Pellet and Roizman, 2007). There are eight human 
and two murine herpesviruses categorized into  α-, β-, and γ-herpesviruses 
based on DNA sequence similarity, genomic arrangement, and tropism. The α-
herpesviruses include herpes simplex virus-1 (HSV-1; HHV-1), herpes simplex 
virus-2 (HSV-2; HHV-2), and varicella zoster virus (VZV; HHV-3). Defining 
characteristics of the α-herpesvirus subfamily include their variable host range, 
short viral replication cycle, and tendency to establish latency in neurons of the 
trigeminal ganglia. The β-herpesvirus members cytomegalovirus (CMV; HHV-5), 
roseolovirus (HHV-6), pityriasis rosea (HHV-7) and murine cytomegalovirus 
(MCMV) are characterized by their restricted host range, long replication cycle, 
and latent infection of secretory glands. Two γ-herpesviruses have been 
identified to naturally infect humans and one γ-herpesvirus has been found to 
naturally infect mice, these include Epstein Barr virus (EBV; HHV-4), Kaposi’s 
sarcoma-associated herpesvirus (KSHV; HHV-8), and murine γ-herpes virus 68 
(MHV-68). γ-herpesviruses are severely restricted to the family or order of their 
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natural hosts and establish latency in lymphocytes and lymphoid tissues. The γ-
herpesviruses are further subdivided in to lymphocryptoviruses, which includes 
EBV, and rhadinoviruses, which includes KSHV and MHV-68. For purposes of 
this dissertation, I will attempt to limit the discussion to the pathophysiology of γ-
herpesvirus infection and its sensing by the innate immune system. 
 
Epstein Barr Virus and Kaposi’s Sarcoma-associated Herpesvirus 
 EBV and KSHV are human γ-herpesviruses and thus are only able to 
naturally infect humans. Virions of both EBV and KSHV contain large, linear 
dsDNA genomes packaged in to an icosahedral protein capsid, which is 
surrounded by a lipid envelope with tegument proteins positioned between the 
capsid and envelope. As with all herpesviruses, the envelopes of EBV and KSHV 
are decorated with glycoproteins (i.e. gB, gH, etc) to mediate virion binding and 
membrane fusion with the target cell during infection, followed by the releasing 
viral capsid and tegument proteins into the cytosol or endosome (Kieff and 
Rickinson, 2007). Viral capsids bearing the dsDNA genome are shuttled to the 
nucleus along microtubules by dynein motors (Kieff and Rickinson, 2007). Once 
outside the nucleus, the capsids bind to nuclear pores and are disassembled to 
allow entry of the genome into the nucleus through the nuclear pore. There, the 
linear dsDNA genome is circularized, within 8 to 12 hours in the case of EBV, 
and chromatinized, recruiting host histones and DNA-binding proteins to the 
genome for early transcription of IE viral genes (Kieff and Rickinson, 2007). 
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Herpesvirus genomes persist in the nucleus as covalently circularized episomes 
during latent infection.  
 EBV is the most widespread of the human herpesviruses with up to 90% 
of adults being seropositive for virus-specific immunoglobulins. EBV is 
transmitted by oral contact to the oropharynx and tonsils, where new infection 
undergoes lytic replication. Acute EBV is asymptomatic in most cases, but it is 
estimated up to 25% of new EBV infections results in infectious mononucleosis 
(IM), characterized by fever, rash, swollen tonsils and lymph nodes, and fatigue. 
EBV transitions to latency after its clearance in the throat, colonizing CD27+ 
memory B cells in the periphery where it enters its latency program (Rickinson, 
2007). Infection of primary human B lymphocytes with EBV in vitro is non-
permissive, rather the entry of the virus into latency is sufficient for their 
conversion into immortalized lymphoblastic cell lines (LCLs) (Rickinson, 2007). 
Two classes of viral antigens are consistently expressed in latently infected B 
cells: six nuclear antigens, referred to as Epstein-Barr nuclear antigens (EBNAs), 
and three membrane proteins, referred to as latency-associated membrane 
proteins (LMPs), each contributing to the establishment and maintenance of 
latency. In addition to these proteins, viral non-coding Epstein Barr-encoded 
RNAs (EBERs) present in the nucleus are also suggested to contribute to latency 
and cellular transformation (Kieff and Rickinson, 2007). EBV infection is closely 
associated with the development of Burkitt’s lymphoma (BL), a malignancy 
commonly found in patients suffering from acquired immunodeficiency syndrome 
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(AIDS) and is also the most common childhood cancer in equatorial Africa. 
Endemic cases of BL are nearly always positive for EBV genome but only 30% of 
AIDS-related BLs cases are EBV+ (Kieff and Rickinson, 2007). Thus, despite its 
clear association with the development of BL, it is unclear whether EBV infection 
of B cells is sufficient for cellular transformation in vivo.  
 Unlike its better-studied family member EBV, the pathogenesis and 
infection cycle of KSHV is less well understood. Initially discovered on the basis 
of its association with the development of Kaposi’s sarcoma (KS), KSHV is the 
most recent of the human herpesvirus to be identified. KSHV prevalence varies 
widely by geographic location with an estimated 3% of the population in the 
United States being seropositive, whereas it rises to near 60% in Africa (Ganem, 
2007). Its transmission occurs both vertically and horizontally but the route of 
infection in which KSHV is passed between humans is unclear. Acute KSHV 
infection is asymptomatic as the virus quickly establishes latent infection, which 
can be detected in endothelial, epithelial, B cells, and monocytes (Cai et al., 
2010). KSHV is associated with the development of several cancers including 
KS, primary effusion lymphoma (PEL), and multicentric Castleman’s disease 
(MCD), most often in immunocompromised adults, but also in children. KSHV is 
most strongly associated with KS, an indolent systemic malignancy characterized 
by oligoclonal tumors of mixed endothelial and lymphocyte origin, presenting as 
papular lesions on the skin. KSHV appears to be required, but not sufficient for 
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the development of KS as nearly 100% of KS tumors are positive for KSHV 
latency-associated nuclear antigen (LANA) (Ganem, 2007).  
 
Murine γ-herpesvirus 68 
 The use of cell culture systems has gone a long way towards 
understanding the molecular mechanisms of replication and latency programs of 
EBV and KSHV. However, their inability to infect and recapitulate pathogenesis in 
animal models has limited the understanding of γ-herpesvirus infection in vivo, at 
least until relatively recently. The isolation of MHV-68 from bank voles and wood 
mice offered the possibility of a robust small mammal model for the study of γ-
herpesvirus pathogenesis (Nash et al., 2001; Collins et al., 2009). Acute MHV-68 
infection of laboratory mice is marked by lytic viral replication in the lung and 
spleen until 9-12 days post infection. This early phase of viral expansion is 
followed by its entrance into latency primarily in B cells, but also lies dormant in 
macrophages and dendritic cells, establishing lifelong persistent infection (Weck 
et al., 1999). The pool of latently infected cells in the spleen is independent of the 
inoculating dose of MHV-68, suggesting host and viral homeostatic mechanisms 
regulate the maintenance of latency and reactivation (Tibbetts et al., 2003). MHV-
68 uses a number of viral proteins to aid in the establishment of latency including 
LANA, vCyclin, vGPCR, vBcl-2 (Barton et al., 2011). 
 The potential for chronic infections to result in chronic inflammation has 
long been appreciated and has fueled speculation about the roles of herpesvirus 
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infections in exacerbating inflammatory diseases in humans. The discovery of 
MHV-68 allows for the study of the role of chronic γ-herpesvirus infection as 
modulator of inflammatory disease processes. The development of 
lymphoproliferative disease (LPD) has been observed during long-term infection 
of Balb/c mice with MHV-68 and systemic immune suppression by cyclosporin A 
further increases the incidence of LPD (Sunil-Chandra et al., 1994). In addition to 
driving de novo carcinogenesis, chronic MHV-68 infection has been shown to 
accelerate and worsen the pathology of other inflammatory conditions in mice. 
Experimental autoimmune encephalitis (EAE), widely considered a model of 
multiple sclerosis, is exacerbated in mice by acute and latent MHV-68 infection 
(Peacock et al., 2003). Development of pulmonary fibrosis is also accelerated by 
chronic MHV-68 infection (McMillan et al., 2008). MHV-68-infected ApoE-/- mice 
develop more severe atherosclerotic lesions (Alber et al., 2000). Chronic infection 
with MHV-68 exacerbated the morbidity, mortality, and colon pathology in the IL-
10-deficiency model of spontaneous colitis (Nelson et al., 2009). Despite these 
finding, little is known about the mechanisms whereby MHV-68 infection 
modulates these disease processes. These data strongly implicate chronic γ-
herpesvirus infection as a modulator of systemic inflammation.  
 
Innate Immune Recognition of γ-herpesviruses 
 Control of viral infection first requires that the virus be recognized by PRRs 
of the innate immune system for the stimulation of acute inflammatory and 
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antiviral programs, as well as for the initiation of virus-specific adaptive 
responses for long-term control of the virus. The mechanisms of γ-herpesvirus 
recognition have been less well studied compared to the other members of the 
herpesvirus (e.g. HSV-1 and CMV), this may reflect the assumption that all 
herpesviruses are recognized through similar mechanisms. The establishment of 
chronic infection by herpesviruses presents a special case for the innate immune 
system. Studies on the mechanisms the innate immune system senses and 
responds to viruses is often studied within the context of acute infection. 
However, sensing of latent and reactivated virus may stimulate innate responses 
through other PRRs more than does acute infection, which may have important 
consequences for the control of persistent virus infection by innate and adaptive 
effector mechanisms. Nonetheless, the innate immune pathways necessary for 
detecting and controlling γ-herpesvirus infection are being elucidated. 
 TLRs 2, 3, and 9 have been implicated in the sensing of EBV, KSHV, and 
MHV-68 infection for the stimulation of the innate immune response. Infection of 
human macrophages and monocytes with EBV activates the NF-κB pathway 
leading to expression proinflammatory cytokines in a TLR2-dependent manner 
(Gaudreault et al., 2007; Ariza et al., 2009). Sensing of the EBV-encoded 
dUTPase by TLR2 has been shown to be sufficient for the expression of 
luciferase driven by NF-κB but how TLR2 recognizes dUTPase is unclear (Ariza 
et al., 2009). Sensing of MHV-68 by TLR2 in mouse embryonic fibroblasts 
(MEFs) has also been revealed to be important for upregulation inflammatory 
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cytokines and type I IFNs (Michaud et al., 2010). TLR2-deficient mice have 
decreased levels of IL-6 and type I IFN and increased viral loads during acute 
MHV-68 infection (Michaud et al., 2010). TLR3 recognizes the EBER non-coding 
RNA of EBV to trigger IRF3 phosphorylation and type I IFN production. EBER is 
present in the sera of patients with active EBV infection and is sufficient for 
induction of type I IFN and inflammatory cytokines when added to cells (Iwakiri et 
al., 2009). Recognition of EBV, KSHV, and MHV-68 genomic DNA by TLR9 
stimulates production of IFN-α in pDCs, but type I IFN production is TLR9-
independent in conventional DCs (cDCs) infected with MHV-68 (Guggemoos et 
al., 2008; Pezda et al., 2011; Fiola et al., 2010; West et al., 2010). Studies in 
mice demonstrated TLR9 is dispensable for the control of MHV-68 during the 
acute phase of infection but required for controlling viral burden during latency 
(Guggemoos et al., 2008).  
 Recent studies have found the sensing of γ-herpesvirus infection also 
occurs through the cytosolic PRRs. In addition to their sensing by TLR3, EBV 
EBERs are also recognized by RIG-I for inducing IFN (Samanta et al., 2006). 
IFI16 has been shown to form an inflammasome with ASC and caspase-1 for the 
processing of IL-1β during de novo KSHV infection of endothelial cells (Kerur et 
al., 2011). Work by Schoggins et al., described higher viral burden in the spleen 
and lungs of cGAS-deficient mice infected with MHV-68, but whether or not 
signaling through cGAS is required for cytokine and IFN upregulation in response 
to MHV-68 was not tested (Schoggins et al., 2014),. Contrary to these findings 
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Dissertation Objectives 
This dissertation has two main focuses: (1) define the pathways responsible for 
inflammasome activation by γ-herpesvirus infection and determine its role for in 
vivo for the immune response to MHV-68 infection, and (2) to determine whether 
DAMPs released into tissues damaged by viral infection modulates the host 
immune response to the virus.   
 
1.1 Investigate the innate immune response to MHV-68 infection. Using primary 
mouse macrophages and dendritic cells, we compared the induction of innate 
immune response genes in response to HSV-1, MCMV, and MHV-68 
infection. We found MHV-68 infection stimulated a milder innate immune 
response compared to HSV-1 and MCMV using Nanostring gene expression 
analysis. 
1.2 Determine the ability of MHV-68 to activate the inflammasome and define the 
sensor necessary for its recognition. We compared MHV-68 stimulated IL-1β 
production by primary mouse macrophages and dendritic cells from mice 
deficient for the inflammasome proteins NLRP3, AIM2, and ASC. Here, we 
found MHV-68 infection resulted in the secretion of IL-1β in a manner 
dependent on ASC and NLRP3.  
1.3 Define the role of the NLRP3 inflammasome for the immune response to and 
control of MHV-68 infection in vivo. Cytokine levels (IL-1β and IFNγ) and viral 
loads during the acute phase, and viral loads during the latent phase were 
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measured in Nlrp3-/-, Asc-/-, and Aim2-/- mice infected with MHV-68. Here, 
we observed decreased amounts of IL-1β and IFNγ in Nlrp3-/- and Asc-/- 
mice during acute MHV-68 infection. NLRP3 and ASC were dispensable for 
controlling viral burden during the acute phase, but Nlrp3-/- and Asc-/- mice 
had higher loads of MHV-68 during latent infection.  
2.1 Investigate the presence and quantities of DNA in the lung microenvironment 
during IAV infection. Histological examination of lungs from IAV infected mice 
indicated the presence of extracellular DNA extruded from necrotic cells. 
Quantification of DNA in the BAL fluid of IAV infected mice revealed the 
amount of DNA in the lung increases as the infection progresses to involve 
more tissue.   
2.2 Determine the role of cytosolic DNA sensors in shaping the immune 
response to IAV infection. First, we found mice deficient for the cytosolic DNA 
sensor AIM2 were susceptible to IAV infection. AIM2 was not required for IL-
1β production by primary mouse dendritic in response to IAV infection in vitro. 
Inflammatory cytokines level and the number of leukocytes recruited to the 
lung were increased in Aim2-/- mice during IAV infection in vivo. AIM2 was not 
required for the control of viral replication or the formation of IAV-specific T 
cell responses. Using Nanostring and qPCR analysis, we compared the 
induction of innate immune response genes in WT and Aim2-/- alveolar 
macrophages to IAV infection ex vivo. Here, we found cell intrinsic effects as 
the expression of several ISGs and cytokines was increased in Aim2-/- 
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macrophages. Taken together, these findings show AIM2 tempers the lethal 
inflammatory response to IAV infection.  
2.3 Determine if DNA released into the lung microenvironment during IAV 
infection is required for protection and dampening of inflammation. We 
generated a recombinant adeno-associated virus vector for ectopic 
expression of DNaseI in the lungs of mice and examined its effect on 
mortality, cytokine responses, and cellular recruitment during IAV infection. 
Wild-type mice treated with the AAV-DNaseI vector had increased numbers of 
T cells lung and were more susceptible to IAV infection. AAV-DNaseI 
treatment had no effect on cytokine responses and viral titers.  
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Defining the role of inflammasomes in innate immune 
responses to gammaherpesvirus infection 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
43
Abstract 
 
 Herpesviruses are a family of dsDNA viruses able to establish lifelong, 
latent infection in their co-evolved hosts. Infection with herpesviruses stimulates 
the innate immune response leading to induction of inflammatory molecules and 
establishment of the antiviral state. An important host response pathway in 
detecting herpesviruses is the inflammasome complex. Sensing of the virus by 
cytosolic NLR or PYHIN proteins stimulates assembly of the complex leading to 
activation of its effector protein caspase-1, which cleaves its downstream 
substrates IL-1β and IL-18 for their activation and secretion. While the receptors 
have been identified for inflammasome activation in response to α-herpesvirus 
(HSV-1) and β-herpesvirus (MCMV), it is unknown whether γ-herpesviruses 
trigger the inflammasome and if so, what receptor is necessary for their 
detection.  In these studies, we found infection with a mouse γ-herpesvirus (MHV-
68) stimulated secretion of IL-1β by APCs in vitro, and this required the cytosolic 
PRR NLRP3, and inflammasome adaptor ASC, but not AIM2. ASC and NLRP3-
deficiency had no effect on controlling viral replication during acute infection, 
however latent viral loads in the spleen were increased in their absence. Taken 
together, we highlight previous uncharacterized role for the inflammasome in γ-
herpesvirus infection. 
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Introduction 
 
 Herpesviruses are important human pathogens that establish lifelong 
latent and recurrent infection. In most cases, acute infection with one of the eight 
human herpesviruses is asymptomatic but can lead to more serious 
complications and pathologies, particularly in the immunocompromised, 
Members of the herpeviridae family are classified into the α, β, and γ subfamilies 
based on genome similarity and tropism. Herpesvirus virions consist of a protein 
capsid containing a  large dsDNA genome and tegument proteins, enveloped in a 
lipid membrane. Infection occurs via fusion of the virion with the plasma 
membrane or entry through the endosomes which ejects the genome containing 
capsid into the cytosol where it quickly shuttles to the nucleus to begin early 
transcription and replication (Pellet and Roizman, 2007). Sensing of viral infection 
by the innate immune system is the first line of defense in host protection against 
herpesviruses (Bowie and Unterholzner, 2008). While much work has been done  
to characterize the innate immune pathways and PRRs important for recognizing 
and stimulating the immune response to HSV-1 and CMV, the innate 
mechanisms responsible for sensing γ-herpesvirus infection are only now being 
elucidated.  
 Viral nucleic acids are believed to be the most important class of 
molecules recognized by PRRs for the stimulation of innate immune and antiviral 
responses (Barbalat et al., 2011). Two important biological responses to viral 
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infection are the production of type I IFN and IL-1β maturation downstream of 
inflammasome activation. In the case of γ-herpesviruses, it has been shown that 
recognition of viral RNA and DNA leads to the induction of type I IFN and 
inflammatory cytokines through endosomal TLRs (Fiola et al., 2010; Iwakiri et al., 
2009). However it has recently been discovered that recognition of viral DNA by 
cytosolic and nuclear DNA receptors is also important for stimulating immune 
responses to herpesvirus infection (Rathinam et al., 2010; Unterholzner et al., 
2010; Kerur et al., 2011; Sun et al., 2013). Sensing of cytosolic DNA induces the 
production of type I IFN and other inflammatory cytokines through the adaptor 
protein stimulator of IFN genes (STING) (Ishikawa et al., 2009). Recognition of 
HSV-1 and CMV viral DNA in the cytosol has been shown occur through cyclic-
GMP-AMP synthetase (cGAS) and interferon-inducible protein 16 (IFI16) 
upstream of STING-dependent cytokines responses (Sun et al., 2013; 
Unterholzner et al., 2010).  
In addition to type I IFN production another important response to viral 
infection is activation of the inflammasome by cytosolic PRRs. The 
inflammasome is a large mutlimeric protein complex comprised of a receptor, the 
CARD and PYRIN domain adaptor protein ASC, and the effector protease 
caspase-1. Assembly and activation of the inflammasome in response to 
microbial and environmental stimuli triggers the processing of caspase-1 into its 
active form which goes on to cleave the inflammatory cytokines IL-1β and IL-18 
into their biologically active forms and allows for their exit from the cell (Davis et 
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al., 2011). Work from our lab has found inflammasome activation by α-
herpesvirus (HSV-1) and β-herpesvirus (MCMV) requires the cytosolic PRRs 
nucleotide-binding oligomerization domain protein-like receptors protein 3 
(NLRP3) and absent in melanoma 2 (AIM2), respectively (Kaminski, 2014; 
Rathinam et al., 2010). AIM2 is a PYHIN protein with a HIN-200 DNA binding 
domain and PYRIN domain able to complex with ASC and caspase-1 forming an 
inflammasome in response to dsDNA (Hornung et al., 2009). NLRP3 on the other 
hand indirectly senses a wide variety of host and microbial molecules. 
Importantly, it has been shown that NLRP3 indirectly senses viral RNA and 
disrupted intracellular ion gradients during influenza A infection leading to 
inflammasome activation (Allen et al., 2009; Ichinohe et al., 2010). It is unclear 
how NLRP3 senses herpesvirus infection and why different herpesviruses 
activate different inflammasomes. However, despite the importance of NLRP3 
and AIM2 in the response to α- and β-herpesviruses, there have been no studies 
to date examining their role in innate responses to γ-herpesvirus infection. 
  The human γ-herpesviruses include Epstein-Barr Virus (EBV; HHV-4) and 
Kaposi’s sarcoma-associated herpesvirus (KSHV; HHV-8). Detection of EBV and 
KSHV viral DNA has been shown to occur through TLR9. It has also been 
reported that IFI16 forms an inflammasome in response to KSHV DNA around 
the nucleus to stimulate caspase-1 and IL-1β activation in endothelial cells.  
However IFI16 does not appear to form an inflammasome in other cell types 
tested (Kerur et al., 2011; Hornung et al., 2009). Nonetheless, a role for 
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inflammasome activation in shaping the immune response to γ-herpesvirus 
infection in vivo has not been examined. In these studies, we found mouse γ-
herpesvirus-68 (MHV-68) stimulated modest IL-1β secretion by APCs in 
response to infection in vitro. Furthermore, sensing of MHV-68 infection by 
NLRP3, but not AIM2, was required for inflammasome activation. NLRP3 and 
ASC were also required for the control of acute lytic replication during in vivo 
MHV-68 infection.  Interestingly, latent viral loads were significantly increased in 
the absence of either NLRP3 or ASC. Collectively, these findings show that 
infection with the γ-herpesvirus MHV-68 activates the NRLP3 inflammasome and 
that this pathway influences the establishment of lytic-latent viral homeostasis.  
 
Results 
 
Characterization of the innate immune response to MHV-68 infection 
 To begin our studies on innate immune recognition and responses to 
MHV-68, we compared the induced expression of immune response genes in WT 
(C57BL/6J) mouse bone-marrow derived macrophages (BMDM) and bone-
marrow derived dendritic cells (BMDCs) in response to representative viruses 
from the α- (HSV-1), β- (MCMV), and γ-herpesvirus (MHV-68) subfamilies. 
Additionally, we compared the responses between a strain of HSV-1 lacking the 
immediate-early protein ICP0 (7134) (Cai and Schaffer, 1989), and the revertant 
WT strain (7134R). ICP0 is a viral E3 ligase able to block the induction of 
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immune response genes downstream of IRF3/7 and NF-κB activation (Lin et al., 
2004; Zhang et al., 2013a). Expression of 94 different immune response genes 
was measured in total RNA purified from cells at 6 hours post-infection using 
Nanostring technology, a fluorescent mRNA barcoding technology for multiplexed 
host-cell transcript quantification.  An MOI 10 was used for each virus to better 
compare the quality of the response to a similar number of infectious virions. 
Infection of WT BMDMs and BMDCs with all the viruses tested induced most of 
the genes on our custom codeset of innate immune response, 
cytokine/chemokines, antiviral genes, and interferon-stimulated genes (ISGs) 
(Fig 2.1 and Appendix II). Of the viruses tested, infection with ICP0-deficient 
strain of HSV-1 7134 stimulated the highest level of induction for most genes 
measured, especially in macrophages (Fig 2.1B). MCMV stimulated higher 
expression for a number of genes in dendritic cells compared to HSV-1 7134, 
however (Fig 2.1C). Infection with the ICP0-sufficient HSV-1 7134R elicited 
significantly weaker esponses compared to HSV-1 7134. Interestingly, ICP0 
appeared to have a stronger effect on blocking PRR signaling in dendritic cells 
compared to macrophages (Fig 2.1 B+C). Infection of both macrophages and 
dendritic cells with MHV-68 stimulated upregulation of most of the genes 
analyzed (Fig 2.1 B+C) however; the responses to MHV-68 were less than those 
to HSV-1 7134 and MCMV. The responses in BMDMs infected with MHV-68 
were, in particular,  lower than the response to HSV-1 and MCMV. In contrast, 
the responses in dendritic cells were more similar across viruses, with exception 
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of  HSV-1 7134R, suggesting they are more sensitized to detecting herpesvirus 
infection than macrophages (Fig 2.1 B). 
Upon closer inspection, we found the upregulation of a number of 
cytokines (Fig 2.2A-D) and ISGs (Fig 2.2E-H) to be particularly low in response to 
MHV-68. Infection of BMDMs and BMDCs with MHV-68 resulted in a dramatically 
lower level of induction of il6, tnfa, and il12b (Fig 2.2A-C), relative to the response 
to HSV-1 7134. For example, HSV-1 7134 infection in BMDMs led to a ~12,000-
fold induction in il6 compared to ~166-fold seen in MHV-68 (Fig 2.2A). 
Expression of il10 was limited to BMDMs but again lower in response to MHV-68 
infection compared to HSV-1 7134 or MCMV (Fig 2.2D). Expression of type I 
IFNs (ifnb1 and ifna4) and the IFN-dependent chemokine cxcl10 was similarly 
lower in response to MHV-68 compared to HSV-1 7134 and MCMV (Fig 2.2D-G). 
Interestingly, expression of stat1, the transcription factor critical to amplifying the 
IFN response, , was similar in response to all viruses (Fig 2.2H). We further 
investigated what affect herpesvirus infection had on the expression of PRRs 
previously demonstrated or implicated in detecting their invasion (Paludan et al., 
2011). Infection with all the herpesviruses stimulated upregulation of tlr2, tlr3, tlr9, 
and ifi204 in both BMDMs and BMDCs (Fig 2.2I-L). Notably, MHV-68 infection 
stimulated upregulation of tlr2, tlr3, tlr9, and ifi204 to similar levels as the other 
viruses. These observations suggest that despite similar expression of PRRs with 
known roles in detecting herpesvirus infection, MHV-68 stimulated a milder 
innate immune response compared to HSV-1 and MCMV.  
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Figure 2.1 MHV-68 induces mild innate immune responses in vitro. (A) 
Heatmap visualization of innate immune response gene expression in BMDMs 
and BMDCs infected with HSV-1 7134 (MOI 10), HSV-1 7134R (MOI 10), MCMV 
(MOI 10), MHV-68 (MOI 10) for 6 hours. Total RNA used for Nanostring analysis. 
Each square represents the normalized transcript count for respective gene and 
virus. (B and C) Upregulation of immune response genes in (B) BMDMs and (C) 
BMDCs infected with herpesviruses. Shown as log2 fold-change over mock 
control. Genes ranked from most to least induced in HSV-1 7134 infected 
samples.  
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Sensing of MHV-68 infection by NLRP3 stimulates inflammasome 
activation and IL-1β secretion. 
 Our lab has long been interested in identifying the cytosolic receptors able 
to activate the inflammasome upon sensing viral infection. We previously 
identified absent in melanoma 2 (AIM2) as the cytosolic DNA receptor required 
for inflammasome activation in response to MCMV but not HSV-1(Rathinam et 
al., 2010). Interestingly, we found sensing of HSV-1 infection by NLRP3 was 
required for inflammasome activation (Kaminski, 2014). Clearly different 
subfamilies of herpesviruses are sensed by different cytosolic PRRs leading to 
inflammasome activation. The mechanisms that determine whether detection of 
herpesviruses occurs by one receptor or another are unknown. In these studies, 
we sought to determine whether γ-herpesvirus infection stimulated inflammasome 
activation, and which receptor is required for this response.  
 To better understand the relationship between transcriptional responses of 
genes for inflammasome components to herpesvirus infection, we examined the 
expression of nlrp3, aim2, casp1, il1b, and il18 in our Nanostring dataset. 
Expression of both nlrp3 and aim2 were both strongly induced by HSV-1 7134 
infection in BMDCs and BMDMs (Fig 2.3A+B). Here, upregulation of aim2 in 
response to MHV-68 was comparable to the other viruses (Fig 2.3B) however; 
induction nlrp3 was low in both BMDMs and BMDCs (Fig 2.3A). Expression of 
the inflammasome effector protease, caspase-1, was upregulated to similar 
levels in response to all the viruses tested (Fig 2.3C). pro-IL-1β  and pro-IL-18 
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are important substrates of caspase-1 downstream of inflammasome activation, 
which are then upon secreted from the cell as inflammatory cytokines. Here, the 
expression of il1b was upregulated to varying levels in response to different 
viruses. Induction of il1b was robust in response to 7134 infection while 7134R, 
MCMV, and MHV-68 induced its expression at much lower, but detectable, levels 
(Fig 2.3D). Expression of il18 was induced to similar levels by infection with all 
the viruses in BMDMs.  In contrast BMDCs appeared to have high basal levels of 
il18 and this gene was induced only in response to MCMV (Fig 2.3E). Broadly, 
infection with all herpesviruses induced the expression of receptors and effectors 
required for inflammasome activation. 
As many of the inflammasome components are induced via common 
transcriptional pathways it is difficult to draw definite conclusions about their 
particular roles based solely on relative expression.  Thus we sought to 
determine which sensor was required for IL-1β secretion in response to MHV-68 
using primary immune cells from mice genetically deficient for inflammasome 
proteins. Since both AIM2 and NLRP3 have been previously shown to be 
required for inflammasome activation in response to herpesviruses, we  
hypothesized MHV-68 would be likely be sensed by one of these receptors. 
Here, we measured IL-1β secretion by primary BMDMs and BMDCs from mice 
deficient in well-described inflammasome receptors in response to MHV-68. Cells 
were first stimulated with LPS in order to upregulate pro-IL-1β expression prior to 
viral infection. Here we found MHV-68 stimulated IL-1β secretion in both BMDCs 
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(MOI 100; Fig 2.4B) and BMDMs (MOI 10; Fig 2.4B), and this required the 
inflammasome adaptor protein ASC, which is required for the recruitment and 
activation of caspase-1 downstream of both NLRP3 and AIM2. IL-1β production 
was low, but detectable, despite the high MOI of MHV-68 used in these 
experiments. In contrast, we saw robust IL-1β production in response to nigericin 
(NLRP3), polydA:dT (AIM2) delivered to the cytosol by lipofectamine transfection, 
and MCMV (AIM2). Nigericin, polydA:dT and MCMV behaved as expected and 
sensing by their respective receptors was required for IL-1β secretion by both 
BMDCs (Fig 2.4A) and BMDMs (Fig 2.4B). Production of IL-1β in response to 
MHV-68 was reduced in both Nlrp3-/- and Asc-/- cells while deletion of AIM2 had 
not no effect in BMDMs (Fig 2.4A) and BMDCs (Fig 2.4B). Similarly deletion of 
other inflammasome sensors including: NLRP1b, NLRP6, NLRP12, and IPAF, 
had no effect on IL-1β secretion in response to MHV-68 (data not shown). 
Together these findings identify NLRP3 as the receptor required for 
inflammasome activation in response to MHV-68.  
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Characterizing the immune response to MHV-68 infection in vivo. A role for 
the inflammasome.  
Upon identifying NLRP3 as the sensor of MHV-68 required for 
inflammasome activation in vitro, we focused our attention to the affect of 
inflammasomes on stimulating immune responses and controlling acute MHV-68 
infection in vivo.  There have been no previous studies investigating what role 
inflammasomes have in shaping the immune response to MHV-68.  Any 
requirement for IL-1R or IL-18R signaling in controlling MHV-68 infection also has 
yet to be described.  During MHV-68 infection, the virus first undergoes robust 
replication in mucosal epithelium tissues and spleen prior to entering latency in 
the spleen after several weeks.  Here we tested whether there was a requirement 
for NLRP3, ASC, and AIM2 in controlling the lytic replication phase of MHV-68 
infection.  Mice were given 5 x 105 pfu of MHV-68 by intraperitoneal injection and 
their spleens and serum were harvested at 6 dpi.  Splenomegaly, a result of early 
B cell proliferation, is a common pathological finding during acute MHV-68 
infection (Weck et al., 1996). Spleen weights significantly increased over mock 
treated controls at 6 dpi with MHV-68 at (Fig 2.5A-C). There was no difference in 
spleen weight of Nlrp3-/- (Fig 2.5A), Asc-/- (Fig 2.5B) and Aim2-/- (Fig 2.5A) 
compared to controls at 6 dpi.  We measured viral loads in the spleen at 6 dpi by 
determining the copy number of viral genomes in DNA extracted from the spleen. 
Nlrp3-/- (Fig 2.5A), Asc-/-  (Fig 2.5B) and Aim2-/- (Fig 2.5A) mice had similar  
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Figure 2.5 AIM2, ASC, and 
NLRP3 are dispensable in 
controlling acute MHV-68 
infection in vivo. (A-C) 
Spleen weights of Nlrp3-/- 
(A), Asc-/- (B), and Aim2-/- 
(C) mice and respective WT 
controls at 6 dpi with 5 x 105 
pfu i.p.. (D-F) Viral loads in 
spleens of Nlrp3-/- (D), Asc-
/-  (E), Aim2-/- (F) and WT 
controls at 6 dpi. DNA 
isolated from spleen tissue 
was use as template to 
quantify number of MHV-68 
genomes present in 
reference to a plasmid 
standard curve. 
Representative of two 
independent experiments *, 
P≤ 0.05; ***, P≤ 0.005 
 
 
 
 
 
 
 
Spleen Weight
M
oc
k
B
6
N
LR
P
3 
-/-
0 0
0.1
0 2
0 3
sp
le
en
 w
ei
gh
t (
g)
***
ns
Spleen Weight
M
oc
k
B
6
A
S
C
-/-
0 0
0.1
0 2
0 3
sp
le
en
 w
ei
gh
t (
g)
*
ns
Spleen Weight
M
oc
k
AI
M
2+
/+
AI
M
2-
/- 
0 0
0.1
0 2
0 3
sp
le
en
 w
ei
gh
t (
g)
n.s.
*
n.s.
M
oc
k
B
6
N
LR
P
3-
/-
0
100
200
300
400
500
Spleen Viral Load
C
op
ie
s 
of
 M
H
V6
8 
gB
/ 1
00
 n
g 
D
N
A ns
M
oc
k
B
6
AS
C
 -/
-
0
500
1000
1500
2000
C
op
ie
s 
of
 M
H
V6
8 
gB
/ 1
00
 n
g 
D
N
A
Spleen Viral Load
ns
M
oc
k
AI
M
2 
+/
+
AI
M
2 
-/-
0
500
1000
1500
2000
Spleen Viral Load
C
op
ie
s 
of
 M
H
V6
8 
gB
/ 1
00
 n
g 
D
N
A ns
NLRP3-/-
ASC-/-
AIM2-/-
DA
B
C
E
F
6 dpi
60
viral loads as their WT counterparts, suggesting the inflammasome is not 
required to control acute MHV-68 infection in the spleen. 
Next, we investigated the role of NLRP3, ASC, and AIM2 in regulating IL-
1β production in the spleen during MHV-68 infection. There was no detectable IL-
1β in the serum at this time but there was a modest increase in IL-1β in the 
spleen at 6 dpi (Fig 2.6A-C).  Despite our in vitro findings, the amount of IL-1β in 
Nlrp3-/-spleen was similar to those in WT mice (Fig 2.6A). Asc-/- spleens had a 
significant reduction in IL-1β however, suggesting the inflammasome complex is 
required for IL-1β responses to MHV-68 (Fig 2.6B). In contrast to response in 
Asc-/- mice, Aim2-/- mice had a notable increase in IL-1β in the spleen compared 
to AIM2 +/+ controls (Fig 2.6C).   
IFNγ is an important cytokine in limiting acute MHV-68 infection (Tsai et 
al., 2011). We have previously shown IFNγ production by NK cells during MCMV 
infection requires the AIM2 inflammasome (Rathinam et al., 2010). Nlrp3-/- mice 
had a marked decrease in IFNγ protein in both the spleen and serum compared 
to WT (Fig 2.6D+G). Surprisingly, IFNγ levels in WT and Asc-/- mice were similar 
in both spleen and serum (Fig 2.6E+H). In line with the observations for IL-1β, 
Aim2-/- mice had increased amounts of IFNγ in the spleen and serum (Fig 
2.6F+I).  
Once early MHV-68 replication is controlled by the immune system at 14 
to 16 dpi, the virus then establishes lifelong latency in germinal center B cells 
(Collins et al., 2009). In a final set of experiments, we measured the effect of 
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NLRP3, ASC, and AIM2 on controlling latent viral burden in the spleen. Nlrp3-/-
and Asc-/- mice had higher copy numbers of MHV-68 DNA in the spleen 
compared to WT at 60 dpi, while AIM2 deficiency had no affect on latent viral 
load (Fig 2.7). These findings suggest a role for the NLRP3 inflammasome in 
controlling the viral burden during latent MHV-68 infection. 
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Figure 2.6 Differential roles for AIM2, ASC, and NLRP3 in regulating early 
IL-1β IFNγ  during MHV-68 infection. Protein Levels of IL-1β (A-C) and IFNγ (D-
F) in spleen homogenates of Nlrp3-/- (A+D), Asc-/- (B+E), and Aim2-/- (C+F) mice 
and respective WT controls at 6 dpi with 5 x 105 pfu i.p.,. (G-I) IFNγ levels in the 
serum of Nlrp3-/- (G), Asc-/-  (H), Aim2-/- (I) and WT controls at 6 dpi. ELISA was 
used to quantitate IL-1β and IFNγ. Representative of two independent 
experiments. P≤ 0.05; **, P≤ 0.01 
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Discussion and Perspectives 
 
 
 In these studies, we aimed to determine: (1) if MHV-68 stimulates the 
innate immune response and how these responses compared to those of other 
herpesviruses,  (2) if MHV-68 is sensed by cytosolic PRRs, and (3) how these 
PRRs affect immune responses in vivo. Infection of antigen-presenting cells 
(APCs) with MHV-68 induced the expression of innate immune response genes 
in a modest manner compared to responses elicited by HSV-1 and MCMV. MHV-
68 infection triggered IL-1β secretion by APCs, and its recognition required the 
inflammasome components NLRP3 and ASC but not AIM2. Mice deficient in 
NLRP3 and ASC had lower IL-1β and IFNγ responses with no effect on viral 
burden during the lytic-phase of MHV-68 infection, but latent viral loads were 
higher in mice lacking NLRP3 and ASC. Interestingly, Aim2-/- mice had increased 
IL-1β and IFNγ responses with no difference in acute or latent viral burden 
suggesting it may suppress inflammation in response to MHV-68 independently 
of its function as an inflammasome receptor. These data taken together begin to 
describe a previous unknown role for the NLRP3 inflammasome in the immune 
response and control of γ-herpesvirus infection. 
  We began our studies comparing the transcriptional responses of 
cytokines/chemokines, ISGs, PRRs, and other immune-related genes to infection 
with an α- (HSV-1), β- (MCMV), or γ-herpesvirus (MHV-68) in primary mouse 
dendritic cells and macrophages (Fig 2.1).  While MHV-68 induced the 
expression of many of the genes we analyzed, this response was milder than 
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those to HSV-1 7134 and MCMV infection at the same MOI. Others have also 
reported MHV-68 as poorly immunogenic, inhibiting type I IFN production and 
cDC maturation despite being able to infect, replicate, and establish latency in 
cDCs (Weslow-Schmidt et al., 2007; Flano et al., 2005). Several mechanisms 
used by the virus to evade PRR recognition have been highlighted in recent 
years. Work by Pezda et al., found the number of TLR9-stimulatory CpG motifs to 
be low in the genome of MHV-68 compared to MCMV and suggested that 
evolutionary pressure has selected for viral species with less immunogenic 
genomes (Pezda et al., 2011). Our own work identified the MHV-68 large 
tegument protein and deubiquitinase (DUB) ORF64 as a suppressor of STING-
dependent cytokine responses, mutation of which increased the type I IFN and 
cytokine response by cDCs (Sun et al., 2015). The conserved herpesvirus kinase 
ORF36 and the tegument protein ORF11 have similarly been shown to target the 
type I IFN pathway by blocking activation of IRF3 and TBK1 downstream of 
STING (Hwang et al., 2009; Kang et al., 2014). Clearly the virus goes to 
considerable lengths to avoid and inhibit detection of viral nucleic acids by PRRs 
leading to type I IFNs, highlighting their importance in controlling MHV-68 
infection. 
Outside the type I IFN response, sensing of viruses by other cytosolic 
PRRs triggers assembly of the inflammasome complex the subsequent 
production of IL-1β and IL-18 secretion. Activation of the NLRP3 and AIM2 
inflammasome is an important step in mounting the immune response to 
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herpesvirus infection. Work from our group has determined inflammasome 
activation in BMDMs and BMDCs by HSV-1 required NLRP3 (Kaminski, 2014), 
and AIM2 was required to respond to MCMV infection (Rathinam et al., 2010).  
Here, we found MHV-68 weakly triggered the secretion of IL-1β in vitro and 
required NLRP3 but not AIM2 for inflammasome activation. It is interesting to 
note that inflammasome activation by the herpesviruses across subfamilies does 
not occur through the same receptor. NLRP3 senses a variety of environmental 
and microbial insults, including a variety of RNA and DNA viruses (Gram et al., 
2012).  Indirect sensing of viral RNA by NLRP3 has been described as a 
mechanism of inflammasome activation for RNA viruses (Allen et al., 2009), 
however the mechanisms of NLRP3 activation in response to DNA viruses is 
entirely unknown. On the other hand, while it is clear the AIM2 inflammasome is 
activated by directly binding dsDNA (Hornung et al., 2009), it is unclear why it 
recognizes MCMV but fails to recognize MHV-68 and HSV-1 infection. One 
plausible explanation is herpesviruses spend little time in the cytosol after 
infecting its host cell. The genome, surrounded by viral capsid, shuttles to the 
nucleus to begin replication and early gene expression, avoiding cytosolic PRRs 
on the way. Once it is in the nucleus the viral genome is quickly chromatinized, 
binding up free histones and other host cell DNA-binding proteins thus further 
masking it from PRRs (Conn and Schang, 2013).  This is not a sufficient 
explanation though given that herpesviruses are clearly sensed by cytosolic and 
endosomal PRRs, thus there appears to be some leaking of nucleic acids and 
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other molecules from the capsid en route to the nucleus. Indeed, we found the 
genome of MHV-68 located in both the cytosol and nucleus early after infection 
(Sun et al., 2015). Viral DNA packaged in the capsid of HSV-1 virions is naked 
and forms electrostatic interactions with capsid proteins to compact the genome 
meaning it should be easily recognized by DNA receptors in the nucleus (Gibson 
and Roizman, 1971; Cohen et al., 1980). If this is the case then why do we not 
see activation of the AIM2 inflammasome by all the herpesviruses? 
Besides localization and chromatinization of the genome there are 
perhaps other active mechanisms used by the virus to circumvent AIM2 
recognition. Mutation of ORF64 increased the IL-1β response to MHV-68 in cDCs 
(Sun et al., 2015), but at what step ORF64 blocks inflammasome priming or 
activation remains to be seen. MHV-68 may have other unidentified proteins 
blocking the inflammasome as well. Indeed, the tegument protein ORF63 (aka 
UL37) of KSHV is a viral NLR homolog able to antagonize the NLRP1, NLRP3, 
and the NOD2 inflammasomes (Gregory et al., 2011). ORF63 of MHV-68 
appears to be a homologous to ORF63 of KSHV and share a remarkable 
similarity to mouse NLRs and is likely to inhibit inflammasome activation as well 
(unpublished analysis).  Viral inhibitors of the inflammasome are likely to be 
found in other herpesvirus subfamilies as well. 
  In addition to AIM2, the human PYHIN protein IFI16 has been shown to 
form an inflammasome complex with ASC and caspase-1 that co-localizes with 
KSHV DNA around the nucleus (Kerur et al., 2011), however our group could not 
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demonstrate the formation of an IFI16 inflammasome in THP-1 cells (Hornung et 
al., 2009). Nonetheless, mice lack an obvious homolog of IFI16 though their 
genome encodes more PYHINs than humans. The function for most of the 
mouse PYHIN proteins is unknown and its possible one of these could form an 
inflammasome in and around the nucleus in response to foreign viral DNA. Work 
from Brunette et al. demonstrated several of the mouse PYHINS induced 
aggregation of ASC when overexpressed in HeLa cells (Brunette et al., 2012), 
thus it is possible several members of the mouse PYHIN proteins may form 
inflammasomes in different cellular compartments and contexts. 
 There have been no studies to date looking at the role of inflammasome or 
IL-1R signaling in the immune response to MHV-68 infection. NLRP3 and ASC 
were required for IL-1β secretion in vitro, however levels of IL-1β in the spleen 
were similar in Nlrp3-/- but decreased in Asc-/- mice (Fig 2.6).  Interestingly, IFNγ 
was decreased in the spleen and serum in Nlrp3-/- but not Asc-/- mice. (Fig 2.6). 
IFNγ is important for controlling viral replication during acute and latent MHV-68 
infection (Tsai et al., 2011; Steed et al., 2006), however NLRP3 and ASC were 
dispensable for controlling acute viral replication suggesting the levels of IFNγ 
were sufficient in either case (Fig 2.5).  AIM2-deficienct mice on the other hand 
had increased amounts of IL-1β and IFNγ during acute infection and a mild 
increase in viral loads. These observations might indicate an inflammasome-
independent function for AIM2 in controlling MHV-68 replication. Whether AIM2 
might limit viral replication in a cellular intrinsic or extrinsic manner remains to be 
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seen. From these studies it appears the inflammasome is not a major pathway in 
controlling acute MHV-68 infection.  
 MHV-68 establishes latency in peritoneal macrophages and B cells in the 
spleen where it ceases to replicate by 16 to 18 dpi. After the establishment of 
latency by MHV-68, low levels of spontaneous and stimulated reactivation occur 
in latently infected cells. Despite no clear effect on limiting viral replication early, 
NLRP3- and ASC-deficient mice had increased loads of latent MHV-68 in the 
spleen at 50 dpi (Fig 2.7).  Viral burden during latent MHV-68 infection is 
independent of the initial dose, and the pool of latently infected cells is held 
stable by homeostatic mechanisms in both the host and virus (Tibbetts et al., 
2003). Many of the host factors controlling the size of the latency pool are 
proteins involved in the induction and signaling of type I IFN. Latent viral loads 
increase in the absence of STING, cGAS, and TLR9 (Sun et al., 2015; Schoggins 
et al., 2014), strongly implicating IFN-dependent regulation of MHV-68 in latency. 
In these studies IL-1R and  IL-18R signaling was implicated as another input 
maintaining the balance between latent virus and host, however further studies 
using mice deficient in IL-1R/IL-18R would support the role of cytokines 
downstream of inflammasome activation in MV-68 infection. 
 In these studies we determined MHV-68 is able to activate the NLRP3 
inflammasome and this was required in vivo for maintaining a low latent viral 
burden. It is important to note that MHV-68 was a weak stimulator of IL-1β in 
vitro, thus even low levels of IL-1R signaling appear to act on latent MHV-68. 
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Special consideration should be taken as we investigate the innate immune 
responses to herpesvirus infection since unlike most viral infections; it 
establishes lifelong latency and parasitism in the host, with periods of reactivation 
providing new antigen and PAMPs to be sensed by the immune system. We 
often investigate the role of PRRs for their ability to detect early viral infection and 
immediate initiation of antiviral and inflammatory programs, however detection of 
reactivated virus by PRRs is likely to have a profound impact on the quality and 
magnitude of memory and inflammatory responses. Further work examining the 
contribution PRRs in the detection reactivating herpesvirus would likely be 
insightful in understanding the long-term immune control of chronic virus 
infection. 
In addition to understanding the immune response to acute γ-herpesvirus, 
the discovery of MHV-68 provides a useful model for studies into latent γ-
herpesvirus infection as a co-factor modulating inflammatory responses to acute 
co-infections and chronic inflammatory conditions. Indeed, transcriptional 
analysis of tissues with latent MHV-68 infection revealed a modest but significant 
upregulation in inflammatory cytokines and immune responses (Canny et al., 
2013). MHV-68 infection protects mice against L. monocytogenes and Y. pestis 
infection by increasing the basal immune activity of latently infected 
macrophages (Barton et al., 2007), and another group reported similar findings 
for influenza infection (Saito et al., 2013). In addition to modulating immune 
responses during co-infection, latent MHV-68 infection has been demonstrated to 
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exacerbate inflammation in models of experimental autoimmune encephalitis and 
atherosclerosis (Peacock et al., 2003; Alber et al., 2000). Highlighting its affect on 
immune responses in the gut, MHV-68 infection accelerated the development of 
colitis with worsened pathology and increased the permeability of the colon 
epithelium in the IL-10-deficiency model of experimental colitis (Nelson et al., 
2009).  Notably, the NLRP3 inflammasome and downstream IL-1R signaling 
have been shown to be important modulators of inflammation in these models 
(Gris et al., 2010; Duewell et al., 2010; Zaki et al., 2010). 
 The potential for chronic herpesvirus infections to drive systemic and local 
inflammation and exacerbate inflammatory disorders in humans long been 
appreciated and speculated upon. EBV and HHV-6 infection in humans is 
associated with the development of systemic lupus erythematosus (SLE), 
rheumatoid arthritis (RA), and multiple sclerosis (MS) amongst others (Lossius et 
al., 2012). Though γ-herpesvirus infection is neither causative nor sufficient to 
drive the development of autoimmunity in susceptible individuals, it is becoming 
increasingly evident that responses controlling latent γ-herpesvirus infection may 
have broader effects on the maintenance of host tolerance. A tempting extension 
of the immune modulatory effects of latent γ-herpesvirus infection is their 
potential contribution in tumorgenesis. The idea that chronic inflammation may be 
a major contributor to tumorgenesis has gained significant support in the 
research community (Trinchieri, 2012). This low grade inflammation or “para-
inflammation” as result of tissue stress or malfunction is commonly found during 
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tumorgenesis, and provides proliferative signals to the cancerous cell (Medzhitov, 
2008). Of the eight human herpesviruses only EBV and KSHV infection are 
associated with the development of cancer, particularly lymphoproliferative 
diseases and lymphoma. There has been much effort implicating transformation 
by EBV and KSHV infection as the causation of lymphomas, but could the 
systemic modulatory effects of latent γ-herpesvirus infection on the immune 
response contribute to the development of cancer? Future works investigating 
para-inflammation surrounding viral latency and the development cancer will be 
insightful as to whether or not these processes are linked. 
 While it is clear that latent γ-herpesvirus infection induces para-
inflammation, the mechanisms used by the innate immune system to detect 
latent infection remain unclear. Viral nucleic acids are the most abundant viral 
product in the cell during latency thus they are likely the main source of signal 
inciting the innate immune system, but several questions remain. How is the DNA 
genome detected by cytosolic receptors once it is wrapped in host histones and 
DNA binding proteins in the nucleus? How is herpesvirus infection sensed by the 
NLRP3 inflammasome but avoids detection by AIM2? What signaling pathways 
mediate para-inflammation during latent infection? Are the modulatory effects on 
the innate immune response by latent γ-herpesvirus infection largely cellular 
intrinsic or systemic? Future studies into the relationship between latent infection 
of cells of the immune system and the homeostatic mechanisms of inflammation 
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and chronic disease would bring more insight into the complicated long-term 
relationships between us and herpesviruses.  
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Chapter 3 
 
DNA in the lung microenvironment during influenza 
virus infection tempers inflammation by engaging the 
DNA sensor AIM2 
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Abstract 
 
Innate sensing of nucleic acids lies at the heart of antiviral host defense. 
However, aberrant activation of innate sensors by host nucleic acids can also 
lead to the development of autoimmune diseases. Such host nucleic acids can 
also be released from stressed, damaged or dying cells into the tissue 
microenvironment. It however remains unclear how the extracellular nucleic acids 
impacts the quality of the host immune responses against viral infections. Using 
a mouse model of influenza A virus (IAV) infection, we uncovered an important 
immune-regulatory pathway that tempers the intensity of the host-response to 
infection. We found that host-derived DNA from necrotic cells accumulates in the 
lung microenvironment during IAV infection, and is sensed by the DNA receptor 
Absent in Melanoma 2 (AIM2). AIM2-deficiency resulted in severe immune 
pathology highlighted by enhanced recruitments of immune cells, and excessive 
systemic inflammation after IAV challenge, which led to increased morbidity and 
lethality in IAV-infected mice. Interestingly, these effects of AIM2 were largely 
independent of its ability to mediate IL-1β maturation through inflammasome 
complexes. Finally, ablation of accumulated DNA in the lung by transgenic 
expression of DNaseI in vivo had similar effects. Collectively, our results identify 
a novel mechanism of cross talk between PRR pathways, where sensing of host-
derived nucleic acids limits immune mediated damage to virus infected tissues.  
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Introduction 
 
Recognition of conserved microbial molecules is a primary strategy by 
which the hosts mount defense responses against infections. These molecules, 
known as pathogen-associated molecular patterns (PAMPs), include bacterial 
components such as lipopolysaccharide (LPS), peptidoglycan, and flagellin.  In 
contrast to those molecules exclusively found in prokaryotes, nucleic acids are 
present in both viral and bacterial pathogens, as well as the host cell they infect. 
All notable species of nucleic acids are recognized by the mammalian innate 
immune system, which leads to potent inflammatory responses including antiviral 
immunity. Recognition of nucleic acids by pattern-recognition receptors (PRRs) 
including RIG-I-like receptors (RIG-I), Nod-like receptors (NLRs), Toll-like 
receptors (TLRs), and PYHIN proteins represent the diverse strategies employed 
by host cells to sense viral infections (Barbalat et al., 2011; Schattgen and 
Fitzgerald, 2011). Sensing of nucleic acids through PRRs triggers signaling 
pathways leading to the production of type I interferons (IFNs), inflammatory 
cytokines, and antiviral molecules including IFN-stimulated genes (ISGs).  
In general, viral nucleic acids recognized by PRRs are largely 
indistinguishable from the nucleic acids found in the host cell. The molecular 
strategies employed by host cells to distinguish self versus non-self nucleic 
acids, and prevent inappropriate activation of nucleic acid sensing PRRs by are 
only beginning to be understood. One such strategy is the physical separation of 
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host nucleic acids and their respective PRRs into distinct subcellular 
compartments. For example, DNA is packaged within the nucleus and 
mitochondria, whereas DNA-sensing PRRs such as absent in melanoma 2 
(AIM2) and toll-like receptor 9 (TLR9) are sequestered in the cytosol and 
endosomes, respectively. The presence of DNA in either of these compartments 
during microbial infections or sterile cellular stress can lead to the activation of 
the DNA sensing machinery. A growing body of evidence indicates that sensing 
of endogenous DNA contributes to the development of autoimmune 
diseases(Kawasaki et al., 2011). Mammalian DNA exonucleases including 
DNaseI, DNaseII, and TREX1 prevent accumulation of endogenous DNA in 
extracellular matrix, phagolysosomes and the cytosol, respectively. Genetic 
mutations in any of these DNase proteins are linked to a spectrum of 
autoimmune diseases (Napirei et al., 2000; Stetson et al., 2008; Kawane et al., 
2006; 2001).   
In addition to the large amounts of viral nucleic acids produced during an 
infection, endogenous danger signals (e.g. DNA) can also be released from dying 
cells.  It is presently unclear if these danger signals are detected and if they in 
turn alter the host’s response to the pathogen. We set out to address this 
question using influenza A virus (IAV).  IAV is an orthomyxovirus with an (-) 
ssRNA genome and the viral life cycle involves the creation RNA species only. 
IAV is sensed by RIG-I (Rehwinkel et al., 2010), as well as TLR7 (Diebold et al., 
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2004), and TLR3 (Le Goffic et al., 2007), all of which mobilize antiviral defenses 
to curb viral replication, prevent viral spread and activate adaptive immunity.  
Here we report the abundant release of endogenous DNA into the lung 
microenvironment during infection with IAV. We identify an important role for the 
DNA sensor AIM2 in sensing this host DNA. Mice lacking AIM2 are hyper 
susceptible to IAV infection. Although AIM2 contributes to the production of IL-1β 
early during IAV infection, the enhanced susceptibility of AIM2-deficient mice is 
not due to a failure to engage IL-1R signaling and IAV specific adaptive immunity. 
Rather, AIM2 appears to function to dampen inflammatory responses that would 
otherwise lead to excessive immunopathology. Thus our study uncovers 
important cross talk between PAMP and DAMP sensing in controlling the 
magnitude of the host response to infection.  
 
Results 
 
DNA accumulates in the lung microenvironment during IAV infection 
 To determine whether host DNA is sensed by the innate immune system 
during viral infections, we first sought a mouse model of viral infection that was 
an RNA virus (with no DNA intermediates), and caused extensive tissue damage 
leading to detectable levels of the host DNA released within the affected tissue. 
For these reasons, we chose the mouse model of IAV infection using the mouse-
adapted PR8 strain since this is an RNA virus capable of causing fatal viral 
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pneumonia. We first set out to determine whether the host DNA was released in 
the lung microenvironment during the course of IAV infection. In the lungs of 
Influenza virus infected mice we detected the extracellular DNA, which was 
primarily localized to the bronchi (Fig 3.1A). The source of this DNA is likely 
necrotic bronchiolar epithelial cells or neutrophil extracellular traps (NETs), both 
of which have previously been identified in IAV infected animals (Capelozzi et al., 
2010; Narasaraju et al., 2011). We also quantified the levels of extracellular DNA 
released within IAV-infected lungs by obtaining bronchiole alveolar lavage (BAL) 
fluid, which were depleted of host cells. Uninfected mice had low, albeit 
detectable quantities of dsDNA  using PicoGreen assay, fluorescent dye specific 
for dsDNA (Fig 3.1B).  We were able to detect a significant increase in the 
amount of DNA as early as 1 day post infection (dpi). The amount of DNA in the 
interstitial space continued to gradually increase at 2, 3, and 6 dpi (Fig 3.1B). 
Since IAV is a single-stranded RNA virus, and produces only RNA intermediates 
during replication (Gultyaev et al., 2010), we conclude that the host-derived DNA 
is the most likely source of DNA in this model. Thus the mouse IAV model fit the 
necessary criteria needed to test our hypothesis. 
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AIM2 protects against lethal IAV challenge independently of the 
inflammasome 
Given the abundance of DNA in the lungs during IAV infection, we next examined 
whether DNA sensing receptor(s) play a role in mediating host immune 
responses to IAV. To this end, we tested mice lacking AIM2, the well described 
DNA receptor required for activation of the inflammasome complex in response 
to cytosolic dsDNA (Hornung et al., 2009; Rathinam et al., 2010; Fernandes-
Alnemri et al., 2009). Previous studies have identified roles for inflammasomes in 
IAV infection (Pang and Iwasaki, 2011). IAV infection has been shown to regulate 
IL-1β via the NLRP3 inflammasome by sensing IAV M2 ion channel and viral 
RNA (Ichinohe et al., 2010; Allen et al., 2009). Further, the inflammasome 
components including ASC and caspase-1 are also required for protection from 
IAV infection (Ichinohe et al., 2009; Allen et al., 2009; Thomas et al., 2009). The 
importance of IL-1 in IAV infection is also supported by the observations that IL-
1R-deficient mice have impaired T cell responses to IAV (Pang et al., 2013). 
Therefore, we first tested whether AIM2 was required for IL-1β production by 
BMDCs in response to IAV in vitro. Treatment of BMDCs with MCMV and poly 
dA:dT, which are known to engage the AIM2 inflammasome, stimulated IL-1β 
secretion in an AIM2-dependent manner, while the NLRP3 dependent stimuli 
ATP and nigericin did so independent of AIM2 as expected (Fig 3.2). Secretion of 
IL-1β by IAV infected BMDCs was independent of AIM2 (Fig 3.2). 
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mRNA (Fig 3.5C+F) were similar between Aim2-/-  and WT mice at both time 
points. These results indicate that there was no defect in Il1b transcription or 
increased negative regulation of IL-1R signaling, respectively. IL-1R signaling 
during IAV infection is required for eliciting a protective flu-specific T cell 
response (Pang et al., 2013). Therefore, we next determined whether AIM2 was 
required for the induction of flu-specific T cell responses, and whether the noted 
decrease in IL-1β was similarly sufficient. After infection with a sublethal dose of 
PR8, we performed tetramer staining using single-cell suspensions from the lung 
and spleen from IAV-infected animals with class I (NP 366, PA 244, PB1 703) 
and class II (NP 311) IAV PR8 epitopes to determine the frequency and the total 
number of flu-specific CD8+ and CD4+ T cells respectively. We found no  
significant difference in the frequency (Fig 3.6A) or number (Fig 3.6B) of 
tetramer-positive CD8+ CD44h  T cells for all class 1 epitopes between WT and 
AIM2-deficient animals in the lungs at 9 dpi.  Similar results were also found in 
the spleen of IAV-infected WT and AIM2-deficient animals for the class I and 
class II T cell epitopes (Fig 3.6C). Taken together, these data indicate that AIM2 
plays a protective role during IAV infection independent of its role on early IL-1β 
production or the formation of flu-specific T cell responses.  
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Figure 3.5 Aim2-/-  mice have intact IL-1β production in vivo during IAV 
infection. (A, D) Levels of IL-1β protein in lung homogenates at 3 dpi (A) and 5 
dpi (D) as determined by ELISA. Relative expression of il1b (B, E) and il1ra 
mRNA (C, F) in the lungs at 3 dpi (B, C) and 5 dpi (D, E). Normalized to GAPDH. 
****, P≤ 0.001 
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in the lungs of Aim2-/- mice were due to an increase in the total numbers of CD4+ 
and CD8+ T cells, immature macrophages, and CD11b+ DCs (Table 3.3).  We 
observed no significant difference in the number of neutrophils, B cells, 
monocytes, or NK cells (Table 3.3). These findings further support the conclusion 
that the protective effect of AIM2 during IAV infection is independent of its role as 
an inflammasome sensor since mice deficient in NLRP3, ASC, and caspase-1 
have been reported to manifest impaired cellular recruitments during IAV 
infection (Ichinohe et al., 2009; Allen et al., 2009; Thomas et al., 2009).  
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The increased number of leukocytes in the lungs of Aim2-/- mice prompted 
us to determine whether inflammatory cytokine responses were similarly 
increased. In line with the decreased IL-1β levels during early infection, we found 
that IL-6 (Fig 3.7A) and TNFα (Fig 3.7B) levels were similarly decreased in lung 
homogenates of Aim2-/- mice at 3 dpi compared to WT controls. However, these 
cytokines (TNFα and IL-6) were significantly elevated in Aim2-/- mice compared to 
WT animals during later infection (Fig 3.7 A + B). The early effects of AIM2-
deficeincy on these cytokines may result from decreased IL-1β production and 
the IL-1R dependent induction of these cytokines. The studies at later time points 
however, suggest that AIM2 has a broader role in dampening inflammatory 
response at later stages of IAV infection.  
 
 
 
 
 
 
Figure 3.7 Altered inflammatory 
cytokine responses in the lungs of 
Aim2-/-  mice. (A) IL-6 and (B) TNFα 
protein in lung homogenates 
measured by ELISA at 3 and 5 dpi. 
(n = 3 independent experiments). *, 
P≤ 0.05; **, P≤ 0.01; ***, P≤ 0.005 
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The heightened inflammatory cytokine responses at later time points could 
be due to increased leukocyte infiltration or cell intrinsic differences in the 
production of these cytokines, or possibly both. To resolve these possibilities, we 
purified alveolar macrophages (AMs) from lungs of naïve mice by FACS sorting 
(SSCh  CD45+ CD11c+ Siglec-F+ autofluoresence+ cells) as previously described 
(Schneider et al., 2014). We compared expression and induction of innate 
immune responses in WT and Aim2-/-  AMs infected ex vivo with IAV PR8 by 
Nanostring gene expression analysis (Table 3.4). Of the 94 immune response 
genes analyzed, 12 of these showed a 2-fold or greater increase in IAV-infected 
Aim2-/-  alveolar macrophages compared to the infected WT sample, while 4 
genes were decreased by 2-fold or more within the same samples (Fig 3.8A). 
Most of the genes showing elevated expression in Aim2-/- AMs were interferon-
stimulated genes (ISGs). Interestingly,Il6 expression was decreased in Aim2-/-  
AMs while Tnfa expression was similar between WT and AIM2-deficient cells (Fig 
3.8A). Amongst the genes that were upregulated in AIM2-deficient cells, cxcl10, 
appeared as a potentially important contributor to the inflammatory phenotype 
observed in Aim2-/-  mice since it functions as a key chemokine driving T cell 
recruitments to the site of infection (Taub et al., 1993). In addition, high levels of 
serum CXCL10 positively correlates with worsened morbidity in patients suffering 
from H5N1 IAV infection (Le Goffic et al., 2006). Expression of cxcl10 in our 
Nanostring analysis was found to be 9.4-fold higher in Aim2-/-  AMs infected with 
IAV when compared to WT (Fig 3.8A). Similar results were also obtained by 
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qPCR (Fig 3.8B). To determine whether the cell intrinsic effects of AIM2 
deficiency were specific to AMs or IAV, we looked at the effect of several PRR 
ligands on cxcl10 expression in WT and Aim2-/-  BMDMs. Expression of cxcl10 
mRNA was significantly higher in Aim2-/-  BMDMs stimulated with IAV, LPS, 
MCMV, and Sendai virus compared to WT controls (Fig 3.8C). Another gene 
implicated as possibly mediating the observed inflammation in Aim2-/-  mice is 
tlr3, an endosomal TLR leading to TRIF-dependent inflammatory cytokine and 
type I IFN induction in response to dsRNA. TLR3 positively regulates 
inflammatory cytokine responses and CD8+ T cell recruitment during IAV 
infection, and mice deficient in TLR3 are protected from immune pathology 
(Napirei et al., 2004). Here we found that infection of WT AMs with IAV led to tlr3 
down-regulation (Fig 3.8A + B). In contrast, we noted a significant increase in tlr3 
expression in Aim2-/-  AMs infected with IAV suggesting AIM2 negatively 
regulates TLR3 signaling (Fig 3.8A + B). Taken together, these results indicate 
that Aim2-/-  macrophages have cell intrinsic differences in innate immune 
responses to IAV that possibly contributes to the heightened inflammation in 
Aim2-/-  mice.  Whether AIM2-defiency has a similar effect on the induction of 
cytokine response in other cell types remains to be determined. 
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Figure 3.8 Aim2-/- macrophages have cellular intrinsic differences in innate 
immune responses to IAV. (A) Heatmap of Nanostring gene expression 
analysis of purified alveolar macrophages infected in vitro with PR8 (MOI 2) for 6 
hours. Selected genes show a 2-fold or greater difference in mRNA counts 
between infected WT and Aim2-/-  alveolar macrophages. Data shown as 
normalized counts of gene-specific probes. (B) qPCR validation of cxcl10 and tlr3 
mRNA expression in WT and Aim2-/-  alveolar macrophages infected in vitro with 
PR8 (MOI 2) for 6 hours. (C) qPCR analysis of cxcl10 mRNA expression in WT 
and Aim2-/-  BMDMs stimulated for 6 hours with IAV  (MOI 2), LPS (200 ng/mL), 
MCMV (MOI 10), Pam3CSK4 (1 ug/mL), and SeV (200 HA U). Shown as relative 
expression normalized to GAPDH.  *, P≤ 0.05; **, P≤ 0.01 
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il1a 64.65 49.54 647.71 749.56 
il1b 3.53 1 769.74 886.72 
il33 1 1 1 1.54 
il4 1 1 1 1 
il12a 1 1 1 1.54 
il12b 1 1 2.58 2.12 
il13 1 1 1 1.54 
il15 1.71 1 5.27 1.54 
il1ra 673.09 574.25 1490.25 1410.69 
il21 1 1 1 1.54 
il23a 1 1 1 1.54 
il6 1 1 30.39 15.99 
irakm 61.92 34.8 184.72 170.1 
irf1 102.96 87.7 512.23 493.73 
irf2 129.42 117.19 133.58 167.02 
irf5 213.34 225.6 361.49 384.31 
irf7 1 1 29.5 79.17 
lgp2 27.25 20.92 59.11 123.87 
md2 89.28 109.39 112.94 110 
mda5 62.83 71.23 143.45 267.19 
mmp2 1 1 1 1.54 
mnda 1 5.31 89.61 171.64 
mndal 29.08 20.92 159.6 237.91 
myd88 109.35 108.52 230.49 227.12 
nfkb1 199.66 191.78 695.27 660.17 
nfkb2 228.85 204.79 802.04 791.17 
nlrc4 42.76 31.33 75.26 88.42 
nlrc5 10.83 9.65 24.11 37.56 
nlrp12 1 1 1 1.54 
nlrp3 32.73 20.06 451.21 490.65 
nlrp6 4.45 1 3.48 2.12 
nos2 2.62 1 1.68 1 
oas2 1 1 3.48 3.66 
prdm1 31.81 23.53 101.28 119.24 
pstpip1 1 1 1 1.54 
rigi 70.13 50.41 187.42 313.42 
rybp 19.04 20.92 15.14 20.61 
samhd1 487.91 414.67 450.32 587.74 
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socs1 1 1 21.42 14.45 
socs3 2.62 1 27.7 39.11 
stat1 133.07 144.94 239.46 509.14 
stat3 365.68 314.07 251.12 264.11 
tgfb1 754.28 667.92 839.73 905.21 
tgfb2 5.36 1 30.39 12.91 
tlr1 1 1 28.6 11.37 
tlr11 1 1 1 1.54 
tlr2 203.31 179.64 514.92 576.95 
tlr3 9.01 9.65 3.48 17.53 
tlr4 84.72 72.96 43.85 79.17 
tlr5 2.62 8.78 1 1.54 
tlr7 175.94 223.87 205.36 305.72 
tlr8 539.91 765.92 397.38 721.82 
tlr9 1 1 1 1.54 
tnfa 102.05 112.86 4012.46 4340.35 
trex1 77.42 79.03 254.71 350.41 
unc93b 679.48 633.23 644.13 737.23 
viperin 1 1.84 76.16 333.46 
yaf2 40.02 47.81 51.93 62.22 
zbp1 2.62 1 23.22 85.34 
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We next sought to better understand the cell-type specific contributions of 
AIM2 in mediating protective immunity against lethal IAV challenge. We 
performed bone marrow transplantations studies to define the role of AIM2 
function in hematopoietic versus non-hematopoietic cells. First, we tested 
whether transplantation of Aim2-/-  bone marrow in WT recipients was sufficient to 
impart susceptibility to IAV infection. Lethally irradiated WT mice were engrafted 
with either Aim2-/-  or control WT bone marrow, and subsequently challenged with 
a lethal dose of IAV to compare survival between the two groups. Here, we found 
that mice reconstituted with Aim2-/-  bone marrow were hypersusceptible to IAV 
infection compared to mice receiving WT bone marrow (Fig 3.9A). These results 
indicate that the expression of AIM2 in the hematopoietic compartment is 
required for protection from IAV. Since the function of AIM2 as a PRR is best 
characterized in myeloid cells, we hypothesized that its expression in 
macrophages and dendritic cells was required for protection.  To answer this 
possibility, we targeted AIM2 deletion in granulocytes/macrophages and dendritic 
cells by crossing mice harboring Aim2f oxed alleles with mice expressing Cre 
recombinase driven by LysM and CD11c, respectively. Surprisingly, we saw no 
differences on mortality following lethal IAV challenge in both LysM-Cre x Aim2fl/fl 
(Fig 3.9B) and CD11c-Cre x Aim2fl/fl (Fig 3.9C) mice compared to Aim2fl/fl 
controls. These results suggest that while AIM2 expression in hematopoietic cells 
is required for protection against IAV infection, its expression in 
granulocytes/macrophages and dendritic cells appears dispensable. Further work 
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is necessary to define the cell-type specific functions of AIM2 during IAV 
infection. The functional role of AIM2 in non-hematopoietic cells is an attractive 
avenue for future studies. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9 Expression of AIM2 in hematopoietic cells is required for 
protection to IAV infection. (A) Survival comparison of lethally irradiated WT 
mice engrafted with WT and Aim2-/- bone marrow infected with PR8. (B) Survival 
comparison of LysM-Cre x Aim2fl/fl and (C) CD11c-Cre x Aim2fl/fl in response to 
IAV infection. Number of mice used indicated next to each experimental group. 
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DNA in the lung microenvironment provides protection to IAV infection 
Having found that genetic deletion of AIM2 increased susceptibility and 
inflammation during IAV infection, we next wanted to determine if the functional 
role of AIM2 was linked to its ability to sense DNA. In particular, we wanted to 
determine if clearance of the extracellular DNA from the lung microenvironment in 
wild type mice would yield a similar effect that was observed in AIM2 deficient 
animals. We hypothesized that the removal the DNA ligand would uncouple the 
contributions of DNA-dependent signaling from the cellular-intrinsic effects 
observed when AIM2 is genetically removed (Fig 3.8). In order to test this 
hypothesis, we generated a recombinant adeno-associated virus (AAV) to 
ectopically express mouse DNaseI in the lungs of C57BL/6 mice (Fig 3.10A). 
DNaseI is a secreted protein, and is normally absent in the lung with respect to 
its enzymatic activity and expression (Napirei et al., 2005). The use of AAV for 
transgene expression in these experiments was ideal due to the relatively low 
immunogenicity of the virus (Mingozzi and High, 2013). The DNaseI transgene 
was packaged using an AAV9 serotype vector since this has a high tropism for 
lung tissues (Bell et al., 2011). Intranasal infection with AAV-DNaseI resulted in 
robust and stable expression of the transgene in the lung two weeks after 
transduction (Fig 3.10B). The DNaseI transgene expression could be detected 
until for at least 3 months (data not shown). Importantly, the levels of DNA in the 
BAL fluid of IAV infected mice were significantly reduced in mice treated with 
AAV-DNaseI compared to GFP expressing control virus (Fig 3.10C). Upon 
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confirming stable expression and functional activity of DNaseI in the lungs of 
AAV-DNaseI treated mice, we wished to determine whether ablation of DNA in 
the lung microenvironment during IAV infection impacted the susceptibility of 
mice to lethality. Following IAV challenge (LD50 of PR8), mice treated with AAV-
DNaseI showed a significant decrease in survival (40%) compared to controls 
(79.6%) out to 14 dpi (Fig 3.10D). Consistent with our observations in Aim2-/-, 
there was no difference in viral load when compared between control and AAV-
DNaseI treated mice at 5 dpi (Fig 3.10E). These results indicate that the 
presence of DNA in the lung microenvironment is protective against lethal IAV 
infection.  
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Figure 3.10 DNA in the lung microenvironment is protective to IAV 
infection. (A) Schematic of ectopic expression of DNaseI. WT mice were given 
1010 pfu of AAV-DNaseI or AAV-GFP intranasally. (B) dnase1 mRNA measured 
by qPCR with total RNA isolated from lungs of AAV-GFP and AAV-DNaseI 
treated mice.  (C) DNA in cell-free BAL in uninfected controls compared to AAV-
GFP and AAV-DNaseI treated mice at 5 dpi with PR8. (n = 2 independent 
experiments) (D) Survival comparison between AAV-GFP and AAV-DNaseI 
treated WT mice challenged with 4 x104 pfu PR8.  Data pooled from two 
independent experiments (AAV-GFP, n = 17; AAV-DNaseI, n = 15). (E) Copy 
number of IAV PA in total lung RNA of AAV-GFP and AAV-DNaseI treated mice 
at 5 dpi. *, P≤ 0.05 
 
 We also characterized the infiltrating leukocyte populations in the lungs of 
AAV-DNaseI treated mice at 5 dpi. Consistent with the effects observed in Aim2-
deficient animals (Table 3.3), we detected significantly elevated numbers of 
CD4+ and CD8+ T cells in AAV-DNaseI treated mice compared to controls 
(Table 3.5). However, the overall number of CD45+ leukocytes was unaffected 
suggesting that the extracellular DNA may signal specifically to regulate T cell 
recruitments to the lungs of infected animals (Table 3.5). We further examined 
the levels of inflammatory cytokines in AAV-DNaseI and control treated mice at 3 
and 5 dpi. Levels of IL-1β, IL-6 and TNFα were comparable between the two 
groups at both time points tested (Fig 3.11A-C). We also investigated the 
expression of chemokines involved in T cell recruitments that could account for 
the increased numbers of T cells in AAV-DNaseI (Table 3.5). Here, we found that 
the expression of cxcl9 was higher in AAV-DNaseI mice compared to controls 
(Fig 3.11D). The cxcl10 levels however were similar between the WT and AIM2-
deficient animals at 5 dpi (Fig 3.11E). Together, these results suggest that DNA 
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Figure 3.11 Inflammatory cytokine responses during IAV infection are 
unaffected by AAV-DNaseI treatment. (A) IL-1β, (B) IL-6, and (C) TNFα protein 
in lung homogenates measured by ELISA at 3 and 5 dpi with IAV. (n = 2 
independent experiments). (D) cxcl9 and (E) cxcl10 mRNA expression in total 
lung RNA at 5 dpi with IAV. Normalized to GAPDH. Data pooled from two 
independent experiments. *, P≤ 0.05 
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Discussion and Perspectives 
 Recognition of foreign nucleic acids lies at the heart of the mammalian 
innate immune surveillance against viral infections. The sensing of viral genomes 
by host-cell PRRs initiate signaling pathways leading to the production of type I 
IFNs, inflammatory cytokines, and other antiviral molecules to mediate potent 
host defense responses. In addition to viral nucleic acids, host-derived nucleic 
acids released from dying cells can also be sensed by the nucleic acid sensing 
machinery. We set out to determine the molecular details and the functional 
consequences of sensing host derived DNA in the broader context of host – 
pathogen interaction. Our studies indicate that host-derived DNA accumulates in 
the lungs following IAV infection, which acts to modulate the intensity and the 
outcomes of the antiviral immune response. The extracellular DNA released into 
the lung microenvironment during IAV infection in turn engages AIM2 to curb 
further immune-mediated tissue damage. AIM2 has largely been studied for its 
role as a dsDNA receptor in the context of the inflammasome complex. Our work 
highlights a novel function for an intracellular DNA receptor in modulating 
immune responses against an RNA virus infection. 
 There is a growing appreciation that the that the immune system cares 
less about the distinction of “self” versus “non-self”, rather it surveys to 
distinguish between “healthy” versus “damaged” states (Matzinger, 1994). Host 
molecules released from stressed and damaged tissues act as DAMPs (or 
alarmins) to alert the innate immune system to damage for the initiation of 
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inflammatory responses. A growing number of endogenous molecules have been 
described to function as DAMPs that modulate inflammatory responses during 
microbial infection and sterile inflammation. Such alarmins include HMGB1, ATP, 
uric acid, RNA and DNA. A growing body of evidence suggests that the sensing 
of host cell DNA is a major mechanism in the onset of autoimmune diseases 
[cite]. Thus, there are considerable efforts by the host to remove unneeded DNA 
before it can accumulate. Deficiency of dnase2a in mouse embryos leads to 
engorgement of liver macrophage phagolysosomes with DNA from the ejected 
nuclei of erythroid precursors, triggering TLR-independent type I IFN responses 
(Okabe et al., 2005). Indeed, DNase2-/- mice are embryonic lethal due to IFN-
driven anemia, and further deletion of the IFN-α/β receptor (IFNAR) recues 
lethality (Kawane et al., 2001; Yoshida et al., 2004). However, DNase2/IFNAR 
double knock-out mice develop chronic polyarthritis driven by IFN-independent 
inflammatory cytokines (Kawane et al., 2006), Similarly, loss of function 
mutations in the DNA exonuclease Trex1 cause Aicardi-Goutieres syndrome 
(AGS) (Crow et al., 2006), a systemic autoimmune disease. Stetson and 
Medzhitov showed that ssDNA derived from reverse-transcribed endogenous 
retroelements accumulating in the cytoplasm as result of Trex1-deficieny, leading 
to cell intrinsic initiation of autoimmune disease (Stetson et al., 2008). Together, 
these studies clearly support the idea that preventing the accumulation of host-
derived DNA essential for normal health 
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 In addition to the cell-intrinsic inflammation driven by the DNA 
accumulation, extrinsic nuclear and mitochondrial DNA provides a danger signal 
to the immune system. An interesting study by Zhang et al. demonstrated that the 
traumatic injury releases mitochondrial DAMPs, including mitochondrial DNA, into 
circulation (Zhang et al., 2010). Mitochondrial DNA sensed by neutrophils 
stimulates their migration, degranulation, and activation of MAPK signaling all 
leading to neutrophil-mediated tissue injury.  Neutrophil responses were 
mediated by the TLR9 sensing of DNA, which could be effectively blocked using 
inhibitory oligodeoxyribonucleutides (iODNs) carrying TTAGGG repeats. Previous 
work from our lab has further showed that the iODNs can broadly regulate 
inflammatory responses downstream of AIM2 and IFI16 by directly interacting 
with these proteins, and competitively binding with activating dsDNA (Kaminski et 
al., 2013). A recent study demonstrated that DNA released by necrotic 
hepatocytes during acetaminophen-induced liver injury drives neutrophil 
recruitment, and liver damage in a TLR9-dependent manner (Marques et al., 
2015). These studies collectively implicate that the recognition of DNA by TLR9 
acts as a major pathway to regulate the inflammatory responses during sterile 
inflammation. Whether extracellular DNA can also function as a DAMP to 
regulate inflammatory processes during microbial infections however remains 
poorly understood. 
Influenza A virus is an orthomyxovirus carrying an RNA genome, which is 
sensed by the RNA sensors RIG-I (Rehwinkel et al., 2010), TLR7 (Diebold et al., 
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2004), and TLR3 (Le Goffic et al., 2007). The only source of DNA during IAV 
infections in our model is the host-derived DNA from either the mitochondrial or 
nuclear origin. IAV infection causes extensive pulmonary pathology including 
extensive necrosis of epithelial cells in the bronchioli (Taubenberger and Morens, 
2008), providing DAMPs capable of activating the immune system. Another 
source of DNA comes in the form of neutrophil extracellular traps (NETs), which 
are released in response to IAV infection (Narasaraju et al., 2011). Here, we 
have found the levels of extracellular DNA in the lung microenvironment 
increased as the IAV infection spread through the tissue (Fig 3.1B). Ablation of 
extracellular DNA in the lung by the ectopic expression of DNase1 in the lung 
imparted susceptibility on WT mice to lethal IAV infection (Fig 3.10D), but had no 
detectable effect on viral burden (Fig 3.10E). Moreover, we observed increased 
recruitment of CD8+ and CD4+ T cells into the lungs of mice treated with the 
AAV-DNaseI (Table 3.5) accompanied by a modest increase in expression of the 
T cell chemoattractant cxcl9 (Fig 3.11D). Whether CXCL9 is itself responsible for 
the increased number of T cells in the lungs of AAV-DNaseI has not been 
explored. Notably, we were unable to detect increased levels of inflammatory 
cytokines in the lungs of treated mice compared to those of controls (Fig 3.11A-
C). These findings are in contrast to the increased levels of TNFα and IL-6 in 
lungs of Aim2-/-  mice at the same time points (Fig 3.7). This observation might be 
explained by one or more possibilities: (1) ectopic expression of DNaseI is unable 
to remove all of the DNA, thus it able to still provide a signal to PRRs, (2) genetic 
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deletion of AIM2 is more complete in blocking the regulatory effect of DNA 
signaling on inflammatory responses or (3) AIM2 deletion has cell intrinsic effects 
regulating the inflammatory response. Further work will determine whether the 
observations in the AAV-DNaseI mice is an uncoupling from the cell intrinsic 
responses in the absence of AIM2, or DNaseI expression is less effective at 
blocking DNA signaling than genetic deletion of AIM2.  
 Having found an abundance of DNA in the lungs during IAV infection, we 
turned our attention to identifying a potential sensor of this DNA able to modulate 
immune responses during infection with an RNA virus. Mice deficient in the 
cytosolic DNA sensor AIM2 were particularly sensitive to IAV infection without a 
detectable difference in viral burden (Fig 3.3 + 4). The best described function of 
AIM2 is its role as a dsDNA receptor able to activate the inflammasome in the 
presence of cytosolic DNA (Hornung et al., 2009), leading to processing of pro-
IL-1β into its active form by the effector caspase-1. Here, we found AIM2 was not 
required for the secretion of IL-1β by dendritic cells in response to IAV in vitro 
(Fig 3.2), As we would predict given the lack of DNA in IAV virions, AIM2 does 
not appear to play a role in direct sensing of IAV. Indeed, the activation of the 
inflammasome by IAV infection has been shown by others to require NLRP3. 
Two inclusive models for NLRP3 activation is through the indirect sensing of viral 
RNA (Allen et al., 2009), and the disruption of intracellular ion gradients by 
insertion of the viral M2 ion pore into the Golgi network (Ichinohe et al., 2010). 
Although AIM2 impacted early IL-1β responses to IAV infection in vivo, this 
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response was indistinguishable from that of wild type mice at later time points 
(Fig 3.5). Similarly, there was no defect in il1b mRNA expression, or increased 
negative regulation of the IL-1R pathway by the natural IL-1R antagonist (Fig 
3.5). Consistent the largely intact IL-1β response, Aim2-/-  mice were able to 
mount normal flu-specific T cell responses (Fig 3.6), which are known to lie 
downstream of IL-1R signaling (Pang et al., 2013), and require caspase-1 and 
the adaptor protein ASC (Ichinohe et al., 2009). From these results, the ability of 
AIM2 in mediating protection against IAV infection appears to be independent 
from its role as an inflammasome sensor. 
  Second to the complicating bacterial pneumonia, fatality due to infection 
with highly pathogenic IAV strains is thought to be the result of excessive 
inflammatory responses dubbed a “cytokine storm” leading to exorbitant 
inflammatory responses and resulting immune pathology (La Gruta et al., 2007). 
Often fatal symptoms of IAV pneumonia include pulmonary edema and acute 
respiratory distress, marked by alveolar hemorrhage and massive numbers of 
mononuclear infiltration (Taubenberger and Morens, 2008). Patients infected with 
the highly pathogenic avian H5N1 were found to have higher serum levels of 
CXCL10, IFNγ, IL-6, and IL-8 than patients infected with a less pathogenic H3N1 
strain (de Jong et al., 2006). Similarly, high levels of the chemokines CXCL10, 
MIG, MCP-1, RANTES and IL-8 positively correlated with disease severity in 
H5N1 infected patients (Peiris et al., 2004). Despite strong correlations between 
excessive cytokines/chemokine production and morbidity, a cohesive mechanism 
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of immune-mediated lung pathology during IAV infection has yet to be described. 
FACS analysis examining cellular infiltration revealed an increase in the number 
of leukocytes recruited to the lungs of Aim2-/- mice (Table 3.3). Immune 
phenotyping of infiltrating leukocytes further demonstrated this was due to 
increased numbers of immature macrophages, CD11b+ dendritic cells, as well as 
CD8+ and CD4+ T cells at 5 dpi (Table 3.3). Interestingly, works investigating the 
role of CD8+ T cells during IAV infection suggest they are an important 
contributor in the development of immune pathology (Moskophidis and Kioussis, 
1998; Wells et al., 1981; Wiley et al., 2001; Small et al., 2001). It is tempting to 
speculate the cause of mortality in Aim2-/-  is attributable to increased numbers of 
CD8+ and CD4+ T cells exacerbating lung pathology during IAV infection 
however, further work is need to formally test this possibility. Analysis of levels of 
the inflammatory cytokines revealed decreased levels of IL-6 and TNFα in the 
lungs of mice deficient for AIM2 at 3 dpi however, levels of both these cytokines 
surpassed those of WT mice by 5 dpi (Fig 3.7). The reason behind the observed 
decrease in IL-6 and TNFα early in infection is unclear and is perhaps related to 
the noted decrease in IL-1β at this time point (Fig 3.5). However, the heightened 
levels of these cytokines at the later time point correlated with the increase in 
leukocytes, thus it is likely there are more cytokine-producing leukocytes in the 
absence of AIM2 at this time point. These data taken together suggest that AIM2 
mice display a “hyper-inflammatory” phenotype during IAV infection and ascribe a 
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new function for AIM2 in regulating inflammatory responses during an RNA virus 
infection in vivo. 
 It is important to note that the phenotype observed in AAV-DNase1 treated 
mice during IAV infection is less severe than Aim2-/-  mice. Indeed, while we 
noted an increase in mortality and T cell infiltration in both groups, mice treated 
with AAV-DNase1 displayed normal cytokine responses compared to their 
controls while Aim2-/-  mice displayed a hyper inflammatory response. As I had 
alluded to in the paragraphs above, one plausible explanation for these 
observations is cellular-intrinsic differences in innate immune responses due to 
the genetic deletion of AIM2. In support of this possibility, previous work in our 
lab has demonstrated Aim2-/-  splenocytes and macrophages produce more IFNβ 
than WT controls in response to cytosolic DNA (Rathinam et al., 2010). Similarly, 
AIM2-deficiency in splenocytes leads to higher expression of several ISGs 
basally, including stat1, viperin, and ifi202 (Panchanathan et al., 2010), but 
decreased expression of the inhibitory IgG receptor, fcgrb2 (Panchanathan et al., 
2011). The mechanism in which AIM2 regulates the expression of ISGs is 
unknown. Differences in host genetic factors between inbred mouse strains have 
been shown to regulate the inflammatory response to IAV infection. The inbred 
mouse strain DBA/2J has been shown to have strong innate immune responses, 
notably increased ISG and proinflammatory cytokines, to IAV infection compared 
to C57BL/6J mice (Alberts et al., 2010). DBA/2J mice are highly susceptible to 
IAV infection and display worsened lung pathology compared to C57BL/6J mice 
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as a consequence of this excessive inflammation (Srivastava et al., 2009). These 
reports provide precedence for exploring whether such intrinsic differences may 
contribute to the underlying pathogenesis to IAV infection we have observed here 
in Aim2-/-  mice. To test this possibility, we compared the expression of innate 
immune-related genes in WT and Aim2-/-  AMs in response to in vitro IAV 
infection. Of the 94 innate response genes on our custom Nanostring codeset, 
expression of 16 genes showed a two-fold or greater difference in Aim2-/-  AMs 
responding to IAV over WT (Fig 3.8A). Notably, induction of il6 was decreased 
and tnfa was unaffected, supporting the possibility the increase we observed for 
these cytokines in lungs of Aim2-/-  mice is due to a greater number of leukocytes 
producing them. In good agreement with previous findings (Panchanathan et al., 
2010), the genes we did find expressed at higher levels in Aim2-/-  AMs were 
mostly ISGs including ifi204, irf7, stat1, ifit1, etc. We found two notable genes, 
tlr3 and cxcl10, whose increased expression could potentially account for the 
increased inflammatory responses of AIM2-deficient mice. A previous reports by 
le Goffic et al. demonstrated IAV is recognized by TLR3, and its deletion in mice 
alleviated mortality and lung inflammation during IAV infection (Le Goffic et al., 
2007; 2006). In our studies, we found the expression of tlr3 was repressed in 
AMs infected with IAV and that deletion of AIM2 alleviated this repression (Fig 
3.8B). Thus, one possibility to consider is sensing of viral RNA through increased 
TLR3 expression in Aim2-/-  mice exacerbates inflammatory responses to IAV in 
vivo. The other gene of interest from our data is the IFN-inducible CXCL10 (aka 
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IP-10), a chemokine able to attract activated CD8+ T cells (Taub et al., 1993) and 
inflammatory monocytes (Lin et al., 2008) expressing the receptor CXCR3. 
Though thought to be largely important in antiviral immunity, the effector 
functions of CD8+ T cells have been strongly implicated as the key cell type 
mediating immune pathology during IAV infection (Moskophidis and Kioussis, 
1998; Wells et al., 1981; Wiley et al., 2001; Small et al., 2001). Indeed, CXCR3-
deficiency impairs entry of CD8+ T cells into the airways of IAV infected mice 
(Fadel et al., 2008). Furthermore, genetic deletion or blocking of CXCL10 with 
monoclonal antibodies during IAV infection improved both survival and lung 
pathology in mice (Wang et al., 2013). In addition to the cell intrinsic effects of 
AIM2 deficiency in AMs, we found expression of cxcl10 to be higher in Aim2-/-  
BMDMs in response to LPS (TLR4), MCMV (cGAS), and SeV (RIG-I), implicating 
a broad role for AIM2 in suppressing cxcl10 expression downstream of multiple 
PRRs. Taken together, CXCL10 is an important chemokine contributing to 
detrimental inflammation during IAV infection. Further work will be insightful in 
determine CXCL10’s contribution in the inflammatory phenotype observed in 
Aim2-/-  mice.  
 Overall, these studies suggest that accumulation of DNA in tissues 
damaged by infection may provide a mechanism for alerting the immune system 
to the extent of tissue damage and function as a signal to limit excessive immune 
pathology. Additionally, we have described a novel function for the DNA receptor 
AIM2 in tempering inflammation during an RNA virus infection. The identification 
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of AIM2 as a regulator of tissue inflammation adds to our understanding of the 
cross talk that exists between innate immune pathways. We theorize that host 
cell DNA signals via AIM2 as a mechanism of sensing tissue damage and 
adjusting the innate response appropriately to mitigate immune pathology 
however, the exact molecular mechanisms extracellular DNA is sensed by AIM2 
and how AIM2 is able to modulate inflammation is unknown. Further work will 
need to be done in order to delineate the cell autonomous effects of AIM2 
deficiency from the relative contribution of DNA sensing by the innate immune 
system.  
Also unknown is whether the mechanism we have identified here is 
specific to viral pneumonia and lung damage brought about by IAV infection 
however, we would predict that similar mechanisms may be at play in other viral 
infections. Further study of endogenous DAMPs and their role in shaping antiviral 
immunity, repair and regenerative responses will also lead to improved 
understanding of viral pathogenesis and could also yield new insights for vaccine 
developments. 
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 The capacity for nucleic acids to stimulate antiviral responses has been 
appreciated for sometime but the means of their sensing through the innate 
immune system have only recently begun to be uncovered. Present in microbes 
and host alike, the presence of nucleic acids outside their normal residence 
provides a signal of infection and damage requiring the attention of the immune 
system. The ability for PRRs to indiscriminately sense nucleic acids allows for 
rapid detection of incoming virus infection to initiate robust antiviral and 
inflammatory responses. There is a price to be paid in gaining this ability 
however as the prolonged signaling by the host’s own nucleic acids through PRR 
pathways can have deleterious effects in the form of autoimmunity and other 
pathologies. Though we tend to think of microbial-derived molecules as the sole 
input signal for initiation of the immune response, fact of the matter is the tissues 
damaged by the pathogen release molecules, including nucleic acids, available 
for sensing by PRRs. These host-derived signals may have significant effect on 
modulating both the innate and adaptive immune responses. Understanding the 
mechanisms for the detection of nucleic acids, as well as how these signals 
integrate, is important expanding our knowledge of the immune response and 
how we might better manipulate these pathways to create better therapeutics and 
vaccines. 
The works presented here examine the receptors and pathways involved 
in the recognition both DNA virus infection and host DNA alike, and how they 
contribute to host defense. Much to our surprise there appears to be a limited 
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role for known DNA sensing pathways in responding to gammaherpesvirus 
infection. In investigating the contribution of the inflammasome in defense against 
gammaherpesviruses we found both NLRP3 and ASC are required both in vitro 
and in vivo for the production of IL-1β, however AIM2 appears to not be involved 
despite MHV-68 being a DNA virus. Though these inflammasome components 
were dispensable in controlling acute phase MHV-68 infection, the higher viral 
burden later on suggest they play an important role in regulating the pool of 
latently infected cells.  
Further highlighting the complexity of innate sensing, we found during 
infection with an RNA virus that host DNA, presumably released for necrotic 
cells, accumulating in the lung microenvironment provides protection. Consistent 
with this observation is that the DNA receptor AIM2 is required for protection from 
influenza infection but not for the control of viral replication. Rather AIM2 appears 
to dampen the magnitude of the inflammatory response to flu as its genetic 
ablation resulted in an increase in the number of recruited immune cells and 
amount of proinflammatory cytokines in the lungs. Interestingly, AIM2 deficiency 
appears to have cell autonomous effects by negatively regulating responses 
through other PRR pathways activated by nucleic acids as well as other 
molecular structures in vitro, however it remains to be determined whether these 
effects regulate responses in vivo. Thinking about the cause of mortality in the 
case of DNA ablation or AIM2-deficiency, I hypothesize that the increased 
number of recruited immune cells leads to exacerbated immune pathology. If this 
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were to be true, then it would suggest that host nucleic acids are recognized by 
the innate immune system as a means of surveying the extent of tissue damage 
during infection to avoid further self-inflicted damage by the immune response. 
Future efforts will help to determine whether this is truly the case and if it applies 
to other scenarios. 
The evolved ability by vertebrates to detect and respond to nucleic acids 
gives a big advantage in the defense against viruses, but these pathways must 
be tightly regulated to prevent their unwarranted activation. While these works 
will help to further our understanding of the mechanisms for recognizing both 
foreign and endogenous molecules, they also serve as an example of the 
complex integration of signals by the innate immune system in order to elicit an 
appropriate immediate response to infection and damage. The sum of the signals 
from multiple PRR pathways dictates the immune response, both qualitatively 
and quantitatively, rather than one molecule or pathway being responsible for 
driving and regulating the response in each case. Investigation into the cross-
regulation of innate sensing pathways should be fruitful and further expand our 
knowledge of the immune system as a whole.  
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Chapter 2 
Animals 
Asc-/- and Nlrp3-/- were used in this study with C57BL/6 controls. Aim2+/+ and 
Aim2-/- mice were generated in our own lab (Rathinam et al., 2010). All 
procedures used in this study complied with federal guidelines and were 
approved by the University of Massachusetts Medical School Institutional Animal 
Care and Use Committee. 
Viruses  
MHV-68 (WUMS strain) and MCMV (Smith strain) were gifts from R Welsh, 
(UMass Medical School).  HSV-1 7134 and 7134 were gifts from D Knipe 
(Harvard Medical School). MHV68 was propagated and titrated in Vero cells in 
Dulbecco’s modified essential medium. MCMV was propagated and titrated in 3T3 
fibroblasts in Dulbecco’s modified essential medium. MCMV and MHV-68 was pelleted 
by ultracentrifugation for 2 h at 4 ̊C at 24,000 rpm, and the pellets were resuspended in 
endotoxin-free sterile Dulbecco’s PBS.  
Generation and culture of mouse macrophages and dendritic cells from 
bone marrow 
Bone marrow cells were harvested from the hind legs of mice. BMDCs were 
cultured in RPMI 1640 medium with 10% heat-inactivated FCS, 200 IU/ml 
penicillin, 100 mg/ml streptomycin and 40 ng/ml GM-CSF (Preprotech). On days 
3 and 5, fresh GM-CSF was added and BMDCs used on days 7 and 8. BMDMs 
were cultured in DMEM containing 10% heat-inactivated FCS, 200 IU/ml 
penicillin, 100 mg/ml streptomycin, and 20% conditioned L929 supernatant. 
Nanostring analysis 
RNA was isolated from cells that were mock infected or infected with HSV-1 
7134, HSV-1 7134R, MCMV and MHV68, at MOI 10. Cells were harvested into 
RLT buffer containing 2-ME for subsequent processing with the RNeasy Mini kit 
(QIAGEN). Each RNA sample was adjusted to contain the same quantity using 
the Nanodrop ND-1000 spectrophotometer (Thermo Scientific). RNA was 
hybridized and quantified with the nCounter Analysis System (NanoString 
Technologies, Seattle, WA) using a customized probe set containing probes for 
innate immune genes, per the manufacturer’s protocol. The gene expression 
data were normalized to an internal positive control, then to an internal negative 
control, and, finally, to seven housekeeping genes: GAPDH, b-glucuronidase, b-
actin, hypoxanthine phosphoribosyltransferase 1, tubulin b, phosphoglycerate 
kinase 1, and clathrin H chain 1. All values were log2 transformed, and a heat 
map was generated using the open source R-based software at the University of 
Massachusetts Medical School.  
123
MHV-68 infection 
Mice were given 5 x 105 pfu MHV-68 in 200 uL sterile PBS by intraperitoneal 
injection. 
Quantification of MHV-68 viral loads 
For detection of viral genomic material, DNA was isolated from spleens using an 
ISOLATE II Genomic DNA Kit (Bioline). Viral genome copy numbers were 
determined by quantification of gB DNA using a plasmid standard curve. For 
amplification of MHV68 glycoprotein B DNA we used the following primers: 
forward: 5’-CCGCTCATTACGGCCCAAATTCAA-3’ and reverse: 5’-
GGCAGCGACAGGCTTTCCATAAAT-3’. The standard plasmid was created by 
insertion of a 121 bp fragment of glycoprotein B DNA amplified with the primers 
and inserted into a TOPO-TA cloning vector (Invitrogen). qPCR was performed 
using iTaq SYBR Green Super Mix (Bio-Rad) and a CFX96 thermocycler (Bio-
Rad). 
Cytokine quantification 
Levels of IL-1β and IFNγ in spleen homogenates was quantified by ELISA 
(eBioscience). Spleen tissues were weighed prior to homogenization in 500 uL 
PBS. Homogenates were spun at 3,000g for 10’ and supernatants were collected 
for analysis. 
Statistical Analysis  
Data were analyzed using the two-tailed Student’s t test comparing means 
between groups. A p-value <0.05 was considered statistically significant. 
Graphing and statistical analyses were done using GraphPad Prism. 
 
Chapter 3 
Animals  
Both Aim2-/- mice generated in our own lab and AIM2fl/fl mice, a kind gift from 
Vishva Dixit, crossed to CMV-Cre mice for germline deletion were used in this 
study (Jones et al., 2010; Rathinam et al., 2010). All knockout mice have been 
backcrossed twelve generations onto the C57BL/6 background. Age- and sex-
matched C57BL/6 (WT) controls were purchased from The Jackson Laboratory 
(Bar Harbor, ME). Itgax-Cre, LysM-Cre, and Vav-Cre transgenic mice were 
purchased from The Jackson Laboratory. All procedures used in this study 
complied with federal guidelines and were approved by the University of 
Massachusetts Medical School Institutional Animal Care and Use Committee.  
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Influenza virus infection  
Influenza virus A/Puerto Rico/8/1934 H1N1 (PR8) grown in chicken eggs was 
purchased from Charles River Laboratories (Wilmington, MA). Mice were first 
anesthetized with isofluorane and inoculated via intranasal route with 4 x 104 pfu 
in 30 uL PBS.  
Measurement of viral load and gene expression  
Total RNA from lung tissue was extracted using Qiazol reagent (Qiagen) and 
reverse transcribed using iScript cDNA Synthesis Kit (Bio-Rad). qPCR assays 
were performed using iTaq Univeral Probes Master Mix or iTaq SYBR Green 
Super Mix (Bio-Rad) using a CFX96 thermocycler (Bio-Rad). Relative gene 
expression was determined using the 2ΔCt method with GAPDH as a 
housekeeping gene. Viral loads were determined by quantification of viral PA 
copy number by TaqMan probes (Trudeau Institute Molecular Biology Core 
Facility, Saranac Lake, NY) using a plasmid standard curve as previously 
described (McKinstry et al., 2009). Dnase I mRNA levels were quantified by 
qPCR using the following primer sequences: mDnaseI fwd 5’- 
TCGCTATGACATCGCTGTTAT-3’, mDnaseI rev 5’-
GTCAGGTTTGTCCCGATTGAG-3’, mGAPDH fwd 5’-
TGGCAAAGTGGAGATTGTTGCC-3’, mGAPDH rev 5’- 
AAGATGGTGATGGGCTTCCCG-3’  
Quantification of DNA in BAL  
BAL was harvested using 1 mL PBS. Cells and other debris in BALF were 
pelleted by centrifugation at 5,000 x g, 10 min, at 4C and supernatants 
harvested. dsDNA in BAL supernatants was quantitated by PicoGreen assay 
using dilutions of calf thymus DNA to make a standard curve.  
Histological analysis  
Lungs were inflated with 1 mL of 10% neutral buffered formalin prior to fixation in 
10% neutral buffered formalin at least overnight. Samples were subsequently 
paraffin- embedded, sectioned for hematoxylin and eosin staining.  
Flow cytometry and tetramer staining  
Mice were perfused with 10 mL PBS in the right ventricle prior to the removal of 
lungs. To make single cell suspensions, lungs were minced with a razor blade 
and strained through a 70 uM cell strainer (BD Biosciences). Prior to staining, Fc 
receptors were blocked using supernatant from 2.4G2 hybridoma cells (anti-
CD16/32). Cells were stained using anti- TCRβ-PerCP-Cy5.5, anti-CD19-PerCP-
Cy5.5, anti-B220-AlexaFluor 488, anti-CD11b-APC-eFluor 780, anti-CD11c-
eFluor 450, anti-Ly6G-PE-Cy7, anti-Ly6C-APC, anti-NK1.1- APC (eBioscience), 
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anti-CD45-V500, anti-CD4-PE-Cy7, and anti-CD8α-PE (BD Biosciences). 
Live/Dead Blue (Life Technologies) was included to determine cell viability 
determined. Data acquisition was performed using a 4-laser LSRII (BD 
Biosciences). For tetramer staining, cells were stained using anti-TCRβ-PerCP-
Cy5.5, anti-CD8α-PE, anti- CD4-PE-Cy7, anti-CD44-APC-eFluor780 and APC-
labeled tetramers Kb/NP 366, Kb/PA 244, Kb/PB1 703, or I-Ab/ NP 311 (Trudeau 
Institute Molecular Biology Core Facility, Saranac Lake, NY) in 100 uL 2% FCS –
PBS. Live cells were gated based on forward and side scatter, and Live/Dead 
Blue negative staining prior to subsequent gating. Analysis was performed using 
FlowJo analysis software (TreeStar).  
Cytokine quantification  
Levels of IL-1β, IL-6, and TNFα in lung homogenates was quantified by ELISA 
(eBioscience). Lung tissues were weighed prior to homogenization in 500 uL 
RIPA buffer. Homogenates were spun at 3,000g for 10’ and supernatants were 
collected for analysis.  
Alveolar macrophage sorting and Nanostring analysis  
Lung single-cell suspensions were blocked with anti-CD16/32 prior to being 
stained with anti-CD45-APC-Cy7 (eBioscience), anti-CD11c-APC (Tonbo 
Biosciences), and anti-Siglec- F-PE (BD Biosciences). Alveolar macrophages 
were defined as SSChi CD45+ CD11c+ Siglec-F+ autofluoresence+ and sorted 
using a BD FACSJazz (Schneider et al., 2014). Sorted alveolar macrophages 
were plated into a 12 well dish in RPMI containing 10% FCS. Cells were infected 
with IAV PR8 at MOI 2. Total RNA was purified at 6 hours post-infection using an 
RNeasy kit (Qiagen). RNA was hybridized and quantified with the nCounter 
Analysis System (NanoString Technologies, Seattle, WA) using a customized 
probe set containing probes for innate immune genes, per the manufacturer’s 
protocol. The gene expression data were normalized to an internal positive 
control, then to an internal negative control, and, finally, to seven housekeeping 
genes: GAPDH, b-glucuronidase, b-actin, hypoxanthine 
phosphoribosyltransferase 1, tubulin b, phosphoglycerate kinase 1, and clathrin 
H chain 1. All values were log2 transformed, and a heat map was generated 
using the open source R-based software at the University of Massachusetts 
Medical School. 
Generation of recombinant adeno-associated virus  
Briefly, mouse DNaseI was cloned into an rAAV vector plasmid carrying a vector 
genome with the expression cassette driven by CMV enhanced chicken β-actin 
promoter and flanked by AAV2 ITRs. The AAV-DnaseI plasmid was co-
transfected into HEK 293 cells with an AAV9 packaging plasmid and adenovirus 
helper plasmid. The recombinant virus was purified by standard CsCl gradient 
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sedimentation method and desalted by dialysis (Gao and Esteves, 2012). Mice 
were first anesthetized with isofluorane and inoculated via intranasal route with 
1010 pfu in 30 μL PBS at least two weeks prior to experiments.  
Bone marrow transplantation 
Recipient mice were lethally irradiated with 600 rad followed by intravenous tail 
injection with 107 donor bone marrow cells. Recipients were put on sulfatrim 
antibiotic water and allowed to rest for 6 weeks after engraftment.  
Statistical Analysis  
Data were analyzed using the two-tailed Student’s t test comparing means 
between groups. Kaplan-Meier survival curves were analyzed by Mantel-Cox log-
rank test. A p- value <0.05 was considered statistically significant. Graphing and 
statistical analyses were done using GraphPad Prism.  
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